IRISIN

/ PILLARS OF LONGEVITY, SCIENCE / By
  1. A comparative study on the effects of high-fat diet and endurance training on the PGC-1α-FNDC5/Irisin pathway in obese and nonobese male C57BL/6 mice
  2. A COMPARISON OF THE EFFECTS OF RESISTANCE AND ENDURANCE TRAINING PROTOCOLS ON SERUM Irisin LEVEL AND ALKALINE …
  3. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein Irisin in biological tissues
  4. A glance at the therapeutic potential of Irisin against diseases involving inflammation, oxidative stress, and apoptosis: an introductory review
  5. A new member of the myokine family: Irisin
  6. A novel interplay between Irisin and PTH: from basic studies to clinical evidence in hyperparathyroidism
  7. A novel treatment for weight reduction by the recombinant “Pichia pastoris” yeast expressing the hybrid protein of “Irisin-furin-transferrin”
  8. A pilot study on the relation between Irisin single-nucleotide polymorphism and risk of myocardial infarction
  9. A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3′ UTR
  10. A randomized-controlled trial pilot study examining the effect of pelvic floor muscle training on the Irisin concentration in overweight or obese elderly women …
  11. A review on Irisin, a new protagonist that mediates muscle-adipose-bone-neuron connectivity
  12. A review on the role of Irisin in insulin resistance and type 2 diabetes mellitus
  13. A role for FNDC5/Irisin in the beneficial effects of exercise on the brain and in neurodegenerative diseases
  14. A Study on the Impact of Irisin
  15. A transient elevated Irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women
  16. A11957 Irisin Lowers Blood Pressure by Improvement of Endothelial Dysfunction via AMPK-Akt-eNOS-NO Pathway in the Spontaneously Hypertensive Rat
  17. AB0057 Decreased Irisin level as risk factor of pathological fractures in rheumatoid arthritis patients
  18. AB0116 DECREASED SERUM LEVEL OF Irisin IN PATIENTS WITH ANKYLOSING SPONDYLITIS
  19. AB0327 SERUM Irisin LEVELS IN HEALTHY WOMEN AND PATIENTS WITH RHEUMATOID ARTHRITIS
  20. AB0349 The serum level of Irisin is decreased in the patients with rheumatoid arthritis
  21. AB0962 Irisin levels are associated with exercise, pain and function in patients with knee osteoarthritis
  22. Abnormal Irisin level in serum and endometrium is associated with metabolic dysfunction in polycystic ovary syndrome patients
  23. Abstract P241: Irisin Protects Mitochondria Function During Pulmonary Ischemia Reperfusion Injury
  24. Acute anaerobic exercise affects the secretion of asprosin, Irisin, and other cytokines–a comparison between sexes
  25. Acute and chronic effects of aerobic exercise on serum Irisin, adropin, and cholesterol levels in the winter season: Indoor training versus outdoor training
  26. ACUTE EFFECT OF ENDURANCE EXERCISE ON PLASMA Irisin AND INSULIN RESISTANCE IN OBESE/OVER WEIGHT WOMEN
  27. Acute Effects of Aerobic Treadmill Exercise Intensity on Expression of Irisin and FNDC5 in Male Mouse
  28. Acute exercise training and circulating Irisin in adult mens
  29. Acute exercise-induced Irisin release in healthy adults: Associations with training status and exercise mode
  30. Acute Postexercise Change in Circulating Irisin Is Related to More Favorable Lipid Profile in Pregnant Women Attending a Structured Exercise Program and to …
  31. Adiponectin profile and Irisin expression in Italian obese children: Association with insulin-resistance
  32. Adropin and Irisin in arterial hypertension, diabetes mellitus and chronic kidney disease.
  33. Adropin and Irisin in patients with cardiac cachexia
  34. Adropin and Irisin levels in a rat model of hypothyroidism
  35. Adropin and Irisin levels in relation to nutrition, body composition, and insulin resistance in patients with end-stage renal disease on chronic hemodialysis and …
  36. Adropin and Irisin: New biomarkers of cardiac status in patients with end-stage renal disease? A preliminary study
  37. Adropin and Irisin: New biomarkers of cardiac status in patients with end-stage renal disease? A preliminary study
  38. Aerobic exercise alleviates oxidative stress-induced apoptosis in kidneys of myocardial infarction mice by inhibiting ALCAT1 and activating FNDC5/Irisin signaling …
  39. Aerobic Exercise Training-induced Increase in Circulating Irisin Level is Associated With Reduced Arterial Stiffness in Obesity
  40. Aerobic exercise training-induced Irisin secretion is associated with the reduction of arterial stiffness via nitric oxide production in adults with obesity
  41. AGE-RELATED CHANGES OF Irisin LEVELS IN PLASMA AND CEREBROSPINAL FLUID OF HUMANS
  42. Alteration of maternal serum Irisin levels in gestational diabetes mellitus
  43. Alteration of serum and cardiac tissue adropin, copeptin, Irisin and TRPM2 expressions in DOX treated male rats
  44. Alteration of the Irisin–brain-derived neurotrophic factor axis contributes to disturbance of mood in COPD patients
  45. Alterations of Irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45 min of a Turkish bath or running
  46. Alterations of Irisin, adropin, preptin and BDNF concentrations in coronary heart disease patients comorbid with depression
  47. Altered Irisin/BDNF axis parallels excessive daytime sleepiness in obstructive sleep apnea patients
  48. An Examination of the Changes in IL-15, CRP and Serum Irisin in Different Rest Intervals after a Session of Resistance Activity in the Elderly
  49. An Investigation into Irisin Levels: Acute and Chronic Effects of Combined Training and Its Association with Anthropometric Variables in Overweight Men
  50. An investigation of serum Irisin levels and inflammatory markers in fibromyalgia syndrome
  51. An Investigation of Serum Irisin Levels in Children Experiencing Convulsive Seizures
  52. AN OVERVİEW OF DİAGNOSTİC VALUES OF IRİSİN AND CYSTATİN C
  53. An update on the role of Irisin in the regulation of endocrine and metabolic functions
  54. An update on the validity of Irisin assays and the link between Irisin and hepatic metabolism
  55. An Updated Mini Review of Acute and Chronic Responses to Exercise Training-induced Irisin in Browning of White Fat
  56. Androgen receptors blockage does not influence the expression of Irisin in myocardium of endurance trained rats
  57. Anti-diabetic activity of recombinant Irisin in STZ-induced insulin-deficient diabetic mice
  58. Anti-inflammatory properties of Irisin, mediator of physical activity, are connected with TLR4/MyD88 signaling pathway activation
  59. Antidepressant-like and pro-neurogenic effects of physical exercise: The putative role of FNDC5/Irisin pathway
  60. Application of the transtheoretical model to predict self-care outcomes and serum Irisin level in the patients with type 2 diabetes
  61. Aquarobic exercises improve the serum blood Irisin and brain-derived neurotrophic factor levels in elderly women
  62. Aqueous humor heat-shock protein 70, periostin, and Irisin levels in patients with pseudoexfoliation syndrome
  63. Are Heart Muscle Irisin Levels and FNDC5 Gene Expression Regulated by Endurance and Resistance Exercises?
  64. Are skeletal muscle FNDC5 gene expression and Irisin release regulated by exercise and related to health?
  65. Assessing cardiac Irisin activities and their associations on coronary and endothelial activities to compare their recoveries from oxidative stress-induced cardiac cell …
  66. Assessment of Irisin concentration in women with stress urinary incontinence after using exracorporeal magnetic innervation (EXMI)-pilot study
  67. Assessment of Irisin levels in patients with bipolar depression and unipolar depression
  68. Assessment of Irisin, adiponectin and leptin levels in patients with schizophrenia
  69. ASSESSMENT OF SERUM Irisin IN OVERWEIGHT AND OBESE PATIENT WITH POLYCYSTIC OVARY SYNDROME
  70. Assessment of serum Irisin level in thyroid disorder
  71. Assessment of Serum Vitamin D and Irisin Levels in Obese Patients.
  72. Associaiton of Irisin and vaspin with clinical presentations of metabolic syndrome in patients with type 2 diabetes mellitus
  73. Association between circulating Irisin and C-reactive protein levels: A systematic review and meta-analysis
  74. Association between circulating Irisin and homocysteine in patients with nonalcoholic fatty liver disease
  75. Association between circulating Irisin and insulin resistance in non-diabetic adults: a meta-analysis
  76. Association between circulating Irisin levels and epicardial fat in patients with treatment-naïve overt hyperthyroidism
  77. Association between circulating Irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in …
  78. Association between insulin resistance and serum and salivary Irisin levels in patients with psoriasis vulgaris
  79. Association between Irisin and homocysteine in euglycemic and diabetic subjects
  80. Association between Irisin and major chronic diseases: a review
  81. Association between Irisin, hs-CRP, and metabolic status in children and adolescents with type 2 diabetes mellitus
  82. Association between plasma Irisin and glucose metabolism in pregnant women is modified by dietary n‐3 polyunsaturated fatty acid intake
  83. Association Between Plasma Irisin in Mid-Pregnancy and Postpartum Glucose Levels Among Chinese Women
  84. Association between plasma Irisin in pregnancy and postpartum glucose levels among Chinese women: a cohort study
  85. Association between Serum Irisin and TNFα in newly onset Diabetic type 2 in Iraqi patients
  86. Association between serum Irisin concentrations and sarcopenia in patients with liver cirrhosis: a cross-sectional study
  87. Association between serum Irisin concentrations and sarcopenia in patients with liver cirrhosis: a cross-sectional study
  88. Association between serum Irisin levels and non-alcoholic fatty liver disease in health screen examinees
  89. Association of circulating adiponectin, resistin, Irisin, nesfatin-1, apelin-12 and obestatin levels with hypertension and obesity
  90. Association of circulating Irisin and cardiopulmonary exercise capacity in healthy volunteers: results of the Study of Health in Pomerania
  91. Association of circulating Irisin concentrations with weight loss after Roux-en-Y gastric bypass surgery
  92. Association of Circulating Irisin Levels with Adiposity and Glucose Metabolic Profiles in a Middle-Aged Chinese Population: A Cross-Sectional Study
  93. Association of circulating Irisin levels with metabolic and metabolite profiles of Korean adolescents
  94. Association of circulating Irisin levels with normal weight obesity, glycemic and lipid profile
  95. Association of circulating Irisin with insulin resistance and oxidative stress in obese women
  96. ASSOCIATION OF CIRCULATING LEVELS OF Irisin AND FGF21 WITH ANTHROPOMETRIC AND METABOLIC PARAMETERS IN ELDERLY PATIENTS WITH …
  97. Association of Irisin and CRP levels with the radiographic severity of knee osteoarthritis
  98. Association of Irisin and FNDC5 rs16835198 G> T gene polymorphism with type 2 diabetes mellitus and diabetic nephropathy. An Egyptian pilot study
  99. Association of Irisin and oxidative stress with biochemical parameters in patients with metabolic syndrome
  100. Association of Irisin circulating level with diabetic retinopathy: a case-control study
  101. Association of Irisin concentration with clinical Parameters in Obesity patient compared with sport individual in Iraqi population
  102. Association of Irisin concentrations with the presence of diabetic nephropathy and retinopathy
  103. Association of Irisin Hormone With Some Physiological And Inflammatory Parameters in Patients With Type 2 Diabetic Mellitus (T2DM) in Thi-Qar Province …
  104. Association of Irisin hormone with some physiological and inflammatory parameters of type 1 diabetic mellitus (TIDM) patiens in Thi-Qar province, Iraq
  105. Association of Irisin plasma levels with anthropometric parameters in children with underweight, normal weight, overweight, and obesity
  106. Association of Irisin serum concentration and muscle strength in normal-weight and overweight young women
  107. Association of Irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index
  108. Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index
  109. Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index
  110. Association of metabolic parameters and rs726344 in FNDC5 with serum Irisin concentrations
  111. Association of plasma fatty acid composition with plasma Irisin levels in normal weight and overweight/obese children
  112. Association of plasma Irisin level with prevalence of type 2 diabetes mellitus and physical activity
  113. Association of plasma Irisin with bone mineral density in a large chinese population using an extreme sampling design
  114. Association of polymorphisms of preptin, Irisin and adropin genes with susceptibility to coronary artery disease and hypertension
  115. Association of serum concentrations of Irisin and the adipokines adiponectin and leptin with epicardial fat in cardiovascular surgery patients
  116. Association of Serum Fibroblast Growth Factor 21 and Irisin with Insulin Sensitivity Markers and Serum Lipids in 12-year-old Children
  117. Association of serum Irisin and body composition with chronic kidney disease in obese Chinese adults: a cross-sectional study
  118. ASSOCIATION OF SERUM Irisin CONCENTRATION WITH CORONARY ARTERY DISEASE IN PATIENTS WITH TYPE 2 DIABETES
  119. Association of Serum Irisin Concentration with Coronary Artery Disease in Patients with Type 2 Diabetes
  120. Association of serum Irisin concentrations with presence and severity of coronary artery disease
  121. Association of serum Irisin concentrations with the presence and severity of obstructive sleep apnea syndrome
  122. Association of serum Irisin with 25 (OH) VD3 and other metabolic indicators in patients with polycystic ovarian syndrome
  123. Association of serum Irisin with metabolic syndrome in obese Chinese adults
  124. Association of the serum Irisin level with obstructive sleep apnea: a body mass index-and physical activity-matched study
  125. Associations of apelin, leptin, Irisin, ghrelin, insulin, glucose levels, and lipid parameters with physical activity during eight weeks of regular exercise training
  126. Associations of betatrophin levels with Irisin in Chinese women with normal glucose tolerance
  127. Associations of circulating Irisin concentrations with cardiometabolic risk factors among children vary by physical activity or sedentary time levels
  128. Associations of Preoperative Irisin Levels of Paired Cerebrospinal Fluid and Plasma with Physical Dysfunction and Muscle Wasting Severity in Residents of Surgery …
  129. Associations of Serum Irisin Level With Brachial Ankle Pulse Wave Velocity and Ankle Brachial Index in Hospitalized Patients
  130. Auricular acupuncture induces FNDC5/Irisin and attenuates obese inflammation in mice
  131. Autonomic function may not modulate Irisin release in healthy adults: findings from a randomized cross-over study
  132. Basic research: Irisin–behind the benefits of exercise
  133. Beneficial effect of voluntary exercise on experimental colitis in mice fed a high-fat diet: the role of Irisin, adiponectin and proinflammatory biomarkers
  134. Biochemical and biological effects of Irisin in a model of diabetes mellitus
  135. Blind spot for sedentarism: redefining the diseasome of physical inactivity in view of circadian system and the Irisin/BDNF axis
  136. Blunted circulating Irisin in adults with type 1 diabetes during aerobic exercise in a hot environment: a pilot study
  137. Bone mineral density in relation to polycystic ovary syndrome: an insight into Irisin and insulin
  138. Bone mineral density in relation to polycystic ovary syndrome: an insight into Irisin and insulin
  139. Boning up on Irisin
  140. Both experimental hypothyroidism and hyperthyroidism increase cardiac Irisin levels in rats.
  141. Both hypothyroidism and hyperthyroidism increase plasma Irisin levels in rats
  142. Brown adipose tissue and browning agents: Irisin and FGF21 in the development of obesity in children and adolescents
  143. Brown adipose tissue in women with polycystic ovary syndrome: relationship with body measures, plasma Irisin levels and the use of metformin
  144. Browning of white fat: does Irisin play a role in humans
  145. C73 NEW MECHANISMS AND THERAPIES IN COPD: Decreased Level Of Irisin, A Skeletal Muscle Cell-Derived Myokine, Is Involved In Emphysema Associated With …
  146. Can Irisin be a linker between physical activity and brain function?
  147. Can Pre-analytical Mistake Bearing Irisin Concentrations Be an Indicator of Coronary Artery Disease?
  148. Can resistance exercise alter Irisin levels and expression profiles of FNDC5 and UCP1 in rats?
  149. Can the Irisin be a biomarker for prostate cancer? A case control study
  150. Cardiometabolic health, visceral fat and circulating Irisin levels: results from a real-world weight loss study
  151. Central and peripheral Irisin differentially regulate blood pressure
  152. Central inhibitory effects on feeding induced by the adipo-myokine Irisin
  153. Central Irisin administration affords antidepressant-like effect and modulates neuroplasticity-related genes in the hippocampus and prefrontal cortex of mice
  154. Central Irisin administration suppresses thyroid hormone production but increases energy consumption in rats
  155. Cerebrospinal fluid Irisin correlates with amyloid-𝜷, BDNF, and cognition in Alzheimer’s disease
  156. Cerebrospinal fluid Irisin correlates with amyloid‐β, BDNF, and cognition in Alzheimer’s disease
  157. Changes and influencing factors of serum Irisin and Galanin level in patients with type 2 diabetes mellitus and obesity
  158. Changes in Inflammatory Cytokines and Irisin in Response to High Intensity Swimming in Adolescent versus Adult Male Swimmers
  159. Changes in Irisin levels in patients with hyperemesis gravidarum
  160. CHANGES IN Irisin RELEASE IN RESPONSE TO PERIPHERAL KISSPEPTIN-10 ADMINISTRATION IN HEALTHY AND OBESE ADULT MEN
  161. Changes in Irisin, titin and dystrophin concentrations in patients with overt thyroid dysfunction
  162. Changes in thyroid hormone levels within the normal and/or subclinical hyper-or hypothyroid range do not affect circulating Irisin levels in humans
  163. Changes of Irisin in patients with end-stage renal disease before and after hemodialysis
  164. Changes of Irisin in patients with end-stage renal disease before and after hemodialysis
  165. Characterization of serum Irisin in patients with severe acute pancreatitis
  166. Characterization of the metabolic effects of Irisin on skeletal muscle in vitro
  167. CHARACTERIZATION OF THE ROLE OF Irisin IN SKELETAL MUSCLE GROWTH AND REPAIR
  168. Chemical Synthesis of the 12 kDa Human Myokine Irisin by α‐Ketoacid‐Hydroxylamine (KAHA) Ligation
  169. Chest Pain is Associated With Decreased Irisin Serum Levels in Type 2 Diabetic Patients With Coronary Artery Disease
  170. Chicoric acid does not restore palmitate-induced decrease in Irisin levels in PBMCs of newly diagnosed patients with T2D and healthy subjects
  171. Chronic exercise training and circulating Irisin in adults: a meta-analysis
  172. Chronic Irisin exposure decreases sexual incentive motivation in female rats
  173. Circulating Adipocyte fatty acid binding protein (FABP4) levels are associated with Irisin in the middle-aged general Chinese population
  174. Circulating Irisin and adiponectin levels are positively associated with atrial fibrillation
  175. Circulating Irisin and chemerin levels as predictors of seizure control in children with idiopathic epilepsy
  176. Circulating Irisin and esRAGE as early biomarkers of decline of metabolic health
  177. Circulating Irisin and glucose metabolism in overweight/obese women: effects of α-lipoic acid and eicosapentaenoic acid
  178. Circulating Irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome
  179. Circulating Irisin and myostatin as markers of muscle strength and physical condition in elderly subjects
  180. Circulating Irisin concentrations are associated with a favourable lipid profile in the general population
  181. Circulating Irisin concentrations in rat models of thyroid dysfunction—effect of exercise
  182. Circulating Irisin confirmed by mass spectrometry
  183. Circulating Irisin detection: Does it really work?
  184. Circulating Irisin in Healthy Adults: Changes after Acute Exercise, Correlation with Body Composition, and Energy Expenditure Parameters in Cross-Sectional Study
  185. Circulating Irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body …
  186. Circulating Irisin in patients with polycystic ovary syndrome: a meta-analysis
  187. Circulating Irisin in relation to insulin resistance and the metabolic syndrome
  188. Circulating Irisin is a Novel Biomarker Providing Prognostic Information in Patients With Heart Failure With Reduced Ejection Fraction
  189. Circulating Irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab …
  190. Circulating Irisin is increased in type 2 diabetes mellitus and correlates with fasting glucose levels
  191. Circulating Irisin is linked to bone mineral density in geriatric Chinese men
  192. Circulating Irisin is lower in gestational diabetes mellitus
  193. Circulating Irisin is reduced in male patients with type 1 and type 2 myotonic dystrophies
  194. Circulating Irisin Level and Thyroid Dysfunction: A Systematic Review and Meta-Analysis
  195. Circulating Irisin Level as an Early Biomarker of Decline of Metabolic Health
  196. Circulating Irisin Level as an Early Biomarker of Decline of Metabolic Health
  197. Circulating Irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events
  198. Circulating Irisin levels and muscle FNDC5 mRNA expression are independent of IL-15 levels in mice
  199. Circulating Irisin Levels and Redox Status Markers in Patients with Gastric Cancer: A Case-Control Study
  200. Circulating Irisin levels are associated with lipid and uric acid metabolism in a Chinese population
  201. Circulating Irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin …
  202. Circulating Irisin Levels Are Not Affected by Coffee Intake: A Randomized Controlled
  203. Circulating Irisin levels are not affected by coffee intake: a randomized controlled trial
  204. Circulating Irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients
  205. Circulating Irisin levels are not regulated by nutritional status, obesity, or leptin levels in rodents
  206. Circulating Irisin Levels Are Not Regulated by Nutritional Status, Obesity, or Leptin Levels in Rodents
  207. Circulating Irisin levels are not regulated by nutritional status, obesity, or leptin levels in rodents
  208. Circulating Irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy
  209. Circulating Irisin levels are positively associated with metabolic risk factors in sedentary subjects
  210. Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease
  211. Circulating Irisin levels as a predictive biomarker for sarcopenia: A cross‐sectional community‐based study
  212. Circulating Irisin levels in children with GH deficiency before and after 1 year of GH treatment
  213. Circulating Irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study
  214. Circulating Irisin levels in newly diagnosed obstructive sleep apnea patients
  215. Circulating Irisin Levels in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
  216. Circulating Irisin levels in response to acute and chronic exercise in obese adults
  217. Circulating Irisin levels of prenatal and postnatal patients with gestational diabetes mellitus: A systematic review and meta-analysis
  218. Circulating Irisin levels reflect visceral adiposity in non-diabetic patients undergoing hemodialysis
  219. Circulating Irisin underscores the development of polycystic ovary syndrome
  220. Circulating Irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk
  221. Circulating levels of betatrophin and Irisin are not associated with pancreatic β-cell function in previously diagnosed type 2 diabetes mellitus patients
  222. Circulating levels of Irisin in hypopituitary and normal subjects
  223. Circulating levels of Irisin in middle-aged first-degree relatives of type 2 diabetes mellitus—correlation with pancreatic β-cell function
  224. Circulating levels of Irisin in obese individuals at genetic risk for Alzheimer’s disease: Correlations with amyloid-β, metabolic, and neurocognitive indices
  225. Circulating levels of Irisin in patients with anorexia nervosa and different stages of obesity–correlation with body mass index
  226. Circulating levels of Irisin is elevated in hypothyroidism, a case-control study
  227. Circulating levels of Irisin is elevated in patients suffering from hypothyroidism and obesity in Hashimoto
  228. Circulating sclerostin and Irisin are related and interact with gender to influence adiposity in adults with prediabetes
  229. Circulating serum Irisin levels in obesity and type 2 diabetes mellitus
  230. Circulating Serum Irisin Levels in Obesity and Type 2 Diabetes Mellitus
  231. Clinical impact of circulating Irisin on classified coronary plaque characteristics
  232. Cloning, prokaryotic expression of human (Homo sapiens) Irisin gene and purification of recombinant protein.
  233. Codon optimization and expression of Irisin in Pichia pastoris GS115
  234. Colostrum and mature breast milk analysis of serum Irisin and sterol regulatory element-binding proteins-1c in gestational diabetes mellitus
  235. Combination of melatonin and Irisin ameliorates lipopolysaccharide‐induced cardiac dysfunction through suppressing the Mst1–JNK pathways
  236. Combined Training Increases the Level of Irisin, Functional Fitness, and Muscle Function in Older Women with Osteosarcopenic Obesity
  237. Combined training, FNDC5/Irisin levels and metabolic markers in obese men: A randomised controlled trial
  238. Comment on Wu and Spiegelman. Irisin ERKs the Fat. Diabetes 2014; 63: 381− 383
  239. Comment on: Effect of sleeve gastrectomy on the expression of Meteorin-like (METRNL) and Irisin (FNDC5) in muscle and brown adipose tissue and its impact on …
  240. Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived ‘browning’factor Irisin, determines insulin sensitivity
  241. Common single nucleotide polymorphisms in the FNDC5 gene are associated with glucose metabolism but do not affect serum Irisin levels in Japanese men with low …
  242. Comparison of Irisin hormone expression between thyroid cancer tissues and oncocytic variant cells
  243. Comparison of Irisin Serum Healthy Untrained Males on Treadmill Exercises by Increasing Gradually Speed Vs Inclination
  244. Comparison of the effect of period of resistance, aerobic and concurrent training on Irisin, CRP serum levels in obese women
  245. Comparison of the effects of regular aerobic training Irisin serum changes in sedentary obese men
  246. Comparison of the effects of two different intensities of combined training on Irisin, betatrophin, and insulin levels in women with type 2 diabetes
  247. Comparison of the Effects of Two Different Intensities of Combined Training on Irisin, Betatrophin, and Insulin Levels inWomen with Type 2 Diabetes
  248. Comparison the effect of eight weeks aerobic training with moderate and high intensities on serum levels of Irisin and Uncoupling Protein 1 (UCP-1) in white adipose …
  249. Comparsion of the effect of resistance program training with different intensities on serum Irisin levels in sedentary young women
  250. Compensatory increased Irisin levels in gestational diabetes mellitus
  251. Comprehensive evaluation of Irisin levels in fetomaternal circulation of pregnant women with obesity or gestational diabetes mellitus
  252. Concentrations of Circulating Irisin and Myostatin in Race and Endurace Purebred Arabian Horses—Preliminary Study
  253. Construction of a Pichia pastoris strain efficiently secreting Irisin and assessment of its bioactivity in HepG2 cells
  254. Copeptin, adropin and Irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus
  255. Cord blood Irisin at the extremes of fetal growth
  256. Cord blood Irisin levels are positively correlated with birth weight in newborn infants
  257. Correlates and Consequences of High Serum Irisin Concentration in Patients on Hemodialysis: A Longitudinal Analysis
  258. Correlation among serum levels of Irisin, insulin resistance and abdominal obesityin patients with first-episode schizophrenia
  259. Correlation between the blood level of Irisin and the severity of acute myocardial infarction in exercise-trained rats
  260. Correlation of Moderate-Intensity Physical Exercise on Irisin, Oxidized-LDL and HDL Level in≥ 50 Years Old Obese Men
  261. Correlations between serum testosterone and Irisin levels in a sample of Egyptian men with metabolic syndrome;(case-control study)
  262. Corrigendum to “Irisin alleviates liver ischemia-reperfusion injury by inhibiting excessive mitochondrial fission, promoting mitochondrial biogenesis and decreasing …
  263. Corrigendum to: Ursolic Acid-Induced Elevation of Serum Irisin Augments Muscle Strength During Resistance Training in Men
  264. Corrigendum to” Irisin Attenuates Angiotensin II-induced Cardiac Fibrosis via Nrf2 Mediated Inhibition of ROS/TGFβ1/Smad2/3 Signaling Axis”[Chem Biol Interact 302 …
  265. Could Irisin levels be affected by physical activity in patients with schizophrenia?
  266. Could serum levels of Irisin be used in gestational diabetes predicting?
  267. COVID-19: Could Irisin Become the Handyman Myokine of the 21st Century
  268. CROSS-TALK BETWEEN MUSCLE AND CARTILAGE: THE MYOKINE Irisin ATTENUATES OSTEOARTHRITIS-RELATED CARTILAGE DEGENERATION
  269. Crossfit training changes brain-derived neurotrophic factor and Irisin levels at rest, after wingate and progressive tests, and improves aerobic capacity and body …
  270. Crosstalk between muscle and bone via the muscle-myokine Irisin
  271. Cystathionine γ-lyase-hydrogen sulfide (H2S) deficiency downregulates muscle myokine Fndc5/Irisin and glucose metabolism in C2C12 myotubes and gastrocnemius …
  272. D41 COPD: BIOMARKERS IN STABLE DISEASE AND EXACERBATIONS: Evaluation Of The Value Of Irisin Levels In Chronic Obstructive Pulmonary Disease (COPD) …
  273. Decrease in Irisin in patients with chronic kidney disease
  274. Decreased concentration of Irisin is associated with poor functional outcome in ischemic stroke
  275. Decreased Irisin secretion contributes to muscle insulin resistance in high-fat diet mice
  276. Decreased level of Irisin, a skeletal muscle cell-derived myokine, is associated with post-stroke depression in the ischemic stroke population
  277. Decreased Level Of Irisin, A Skeletal Muscle Cell-Derived Myokine, Is Involved In Emphysema Associated With Chronic Obstructive Pulmonary Disease Through …
  278. Decreased levels of Irisin, a skeletal muscle cell-derived myokine, are related to emphysema associated with chronic obstructive pulmonary disease
  279. Decreased saliva/serum Irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathology
  280. Decreased Serum Levels of Irisin are Associated with the Development of Chronic Lung Allograft Dysfunction after Bilateral Living-Donor Lobar Lung Transplantation
  281. Delivery vehicle of muscle-derived Irisin based on silk/calcium silicate/sodium alginate composite scaffold for bone regeneration
  282. Detection and quantitation of circulating human Irisin by tandem mass spectrometry
  283. Detection and quantitation of Irisin in human cerebrospinal fluid by tandem mass spectrometry
  284. Diabetes Mellitus Influences the Pattern of Distribution of Irisin in Pancreatic Islet Cells
  285. Diet quality is associated with circulating C-reactive protein but not Irisin levels in humans
  286. Differences in analytical and biological results between older and newer lots of a widely used Irisin immunoassay question the validity of previous studies
  287. Differentiating SGBS adipocytes respond to PPARγ stimulation, Irisin and BMP7 by functional browning and beige characteristics
  288. Differentiating SGBS adipocytes respond to PPARγ stimulation, Irisin and BMP7 by functional browning and beige characteristics
  289. Dihydromyricetin stimulates Irisin secretion partially via the PGC-1α pathway
  290. Disordered metabolism in mice lacking Irisin
  291. Does high intensity exercise affects Irisin plasma levels in hemodialysis patients? A pilot study
  292. Does Irisin has neuroprotective effect against diabetes induced neuropathy in male rats?
  293. Does Irisin have a BRITE future as a therapeutic agent in humans?
  294. Does Irisin Have an Effect on Female Reproductive Function? Initial in-Vitro Studies
  295. Does Irisin Link Physical Exercise with Alzheimer’s Disease?
  296. Does one bout of high intensity resistance training change circulatory levels of Irisin?
  297. Dojuksan ameliorates tubulointerstitial fibrosis through Irisin-mediated muscle-kidney crosstalk
  298. Down-regulation of soluble α-Klotho is associated with reduction in serum Irisin levels in chronic obstructive pulmonary disease
  299. DSS-induced colitis produces inflammation-induced bone loss while Irisin treatment mitigates the inflammatory state in both gut and bone
  300. Early life adversity is associated with elevated levels of circulating leptin, Irisin, and decreased levels of adiponectin in midlife adults
  301. Eccentric resistance training and β-hydroxy-β-methylbutyrate free acid affects muscle PGC-1α expression and serum Irisin, nesfatin-1 and resistin in rats
  302. Editorial Retraction: A Review on the Role of Irisin in Insulin Resistance and Type 2 Diabetes Mellitus
  303. Effect of 12 weeks of light and heavy interval training on the level of Irisin and fibroblast growth factor 21 in obese and overweight women: A clinical trial study
  304. Effect of 14 days of experimental horizontal bed rest on circulating levels of Irisin
  305. Effect of 8 Weeks Exercise On Irisin in Obese Women
  306. Effect of 8 weeks of hypocaloric diet and physical activity on thyroid hormones, Irisin and insulin sensitivity in obese otherwise healthy subjects.
  307. Effect of 8 Weeks Resistance Training and Irisin Injection on BDNF and Spatial Memory of Male Mice
  308. Effect of Acute Handball Training on Irisin, Leptin and Some Biochemical Parameters for Adolescence Handball Players.
  309. Effect of Acute Resistance Training on Plasma Irisin Protein Level and Expression of Muscle FNDC5 and Adipose Tissue UCP1 Genes in Male Rats.
  310. Effect of Adipose Tissue-Derived Stem Cell Transplantation and Six Weeks of Aerobic Exercise on FNDC5 and Irisin Levels in Streptozotocin-Induced …
  311. Effect of aerobic training and resistance training on circulating Irisin level and their association with change of body composition in overweight/obese adults: a …
  312. Effect of aerobic training intensity on Irisin in streptozotocin-induced diabetic rats
  313. Effect of an acute exercise bout on immediate post‐exercise Irisin concentration in adults: a meta‐analysis
  314. Effect of carnosine supplementation on apoptosis and Irisin, total oxidant and antioxidants levels in the serum, liver and lung tissues in rats exposed to formaldehyde …
  315. Effect of carnosine, methylprednisolone and their combined application on Irisin levels in the plasma and brain of rats with acute spinal cord injury
  316. Effect of chronic aerobic exercise training on serum Irisin level in type 2 diabetic rats
  317. Effect of Chronic Exercise on Irisin Plasma Level and Browning of White Adipose Tissue in Rat Models with Obesity or Type 2 Diabetes Mellitus
  318. Effect of cold and moderate water immersion during resistance exercise on plasma Irisin protein response in rats
  319. Effect of Different Exercise Mode and Ur-solic Acid Supplementation on FNDC5 and UCP1 Gene Expression and Plasma Irisin in Rats
  320. Effect of different rest interval between sets of resistance exercise on serum Irisin and blood lactate levels in obese male children
  321. Effect of Eight Weeks’ Resistance Training on Serum Levels of Irisin and Lipid Profile in Overweight Men’s with Nonalcoholic Fatty Liver Disease
  322. Effect of electroacupuncture combined with treadmill exercise on body weight and expression of PGC-1α, Irisin and AMPK in skeletal muscle of diet-induced obesity …
  323. Effect of Ethanol Diet on the circulating levels of Myonectin and Irisin
  324. Effect of exercise intensity on cerebral and muscular brain-derived neurotrophic factor. Connection with the myokine Irisin
  325. Effect of exercise on concentrations of Irisin in overweight individuals: a systematic review
  326. Effect of exercise on serum Irisin level in normal and diabetic rats
  327. Effect of exercise-induced Irisin on myocardial fibrosis
  328. Effect of High Intensity Interval Training (HIIT) on Level of Irisin and Insulin Resistance Index in Rats
  329. Effect of High-Intensity Interval Training (HIIT) on the Levels of Irisin and Interleukin-10 in Overweight Men
  330. Effect of HIIT with Tabata Protocol on Serum Irisin, Physical Performance, and Body Composition in Men
  331. Effect of Irisin on Endometrial Function in Obese Rats
  332. Effect of Irisin on endometrial receptivity of rats with polycystic ovary syndrome
  333. Effect of Irisin on Experimentally-Induced Preeclampsia in Female Albino Rats
  334. Effect of Irisin on hypoxic-ischemic brain damage in neonatal rats
  335. Effect of Irisin on LIF and integrin αvβ3 in rats of implantation failure
  336. Effect of Irisin on Pressure Overload–Induced Cardiac Remodeling
  337. Effect of Long-Term Moderate Physical Exercise on Irisin between Normal Weight and Obese Men
  338. Effect of metformin treatment on insulin resistance markers, and circulating Irisin in women with polycystic ovarian syndrome (PCOS)
  339. Effect of Mixed‐Carotenoid Supplementation and Physical Activity on Irisin and Adiponectin: A 6‐Month Double Blind Placebo‐Controlled Pilot Study in Children with …
  340. Effect of obesity and exercise on the expression of the novel myokines, Myonectin and Irisin
  341. Effect of one session of high-intensity resistive activity on Irisin, IL-15, IL-6 and TNF-α plasma levels in sedentary young women
  342. Effect of single bout downhill running on the serum Irisin concentrations in rats
  343. Effect of sitagliptin on expression of skeletal muscle peroxisome proliferator-activated receptor γ coactivator-1 α and Irisin in a rat model of type 2 diabetes mellitus
  344. Effect of six weeks high intensity interval training with turmeric supplementation on Irisin and UCP1 in obese females
  345. Effect of sleeve gastrectomy on the expression of meteorin-like (METRNL) and Irisin (FNDC5) in muscle and brown adipose tissue and its impact on uncoupling …
  346. Effect of sprint training on resting serum Irisin concentration—sprint training once daily vs. twice every other day
  347. Effect of Swimming on Serum Irisin Levels in Experimentally-Induced Rat Model of Postmenopausal Osteoporosis
  348. Effect of Swimming Training along with Omega-3 Intake on Irisin and Body Composition in Obese Girls with Down Syndrome
  349. Effect of training and gender on plasma Irisin, leptin, and insulin levels
  350. Effect of two weeks of sprint interval training combined with omega-3 consumption on serum levels of Irisin, BDNF and Lipid profile in overweight girls
  351. Effect of Two-Week Swimming Training on the Expression of Irisin Protein in Lumbar Spine of Rats with Neuropathic Pain
  352. Effect of ursodeoxycholic acid therapy due to pregnant intrahepatic cholestasis on chemerin and Irisin levels
  353. Effect of vitamin D supplementation and muscular exercise on Irisin serum level and related metabolic parameters in type II diabetic albino rats
  354. Effect of Vitamin D3 Administration on Irisin Levels in Vitamin D Deficient Rat Model
  355. Effect of Yoga Exercises on Irisin Hormone in Obese People
  356. Effects and molecular mechanism of GST-Irisin on lipolysis and autocrine function in 3T3-L1 adipocytes
  357. Effects and underlying mechanisms of Irisin on the proliferation and apoptosis of pancreatic β cells
  358. Effects of 12 weeks Combined exercise on Physical fitness, Irisin and BNDF in White-collar woman workers
  359. Effects of 12 weeks resistance training on serum Irisin in older male adults
  360. Effects of 8-week combined training (aerobic and resistance) on serum levels of Irisin and leptin in overweight men
  361. Effects of a 1‐year exercise and lifestyle intervention on Irisin, adipokines, and inflammatory markers in obese children
  362. Effects of a Combined Endurance/Strength Training Program on Circulating Irisin Levels in Overweight/Obese Men and Women with Type 2 Diabetes Mellitus
  363. Effects of Aerobic and Resistance Training on Expression of Circulating Irisin
  364. Effects of aerobic exercise in manipulated environment on serum levels of BDNF, Irisin and Cathepsin B in healthy active men
  365. Effects of aerobic training, resistance training, or both on circulating Irisin and myostatin in untrained women
  366. Effects of aged garlic extract and endurance exercise on skeletal muscle FNDC-5 and circulating Irisin in high-fat-diet rat models
  367. Effects of body weight reduction on serum Irisin and metabolic parameters in obese subjects
  368. Effects of Carnosine and Vitamin E on Nucleobindin 2 (NUCB2)/nesfatin-1, Ghrelin, Adropin, and Irisin in Experimentally Induced Ovarian Torsion
  369. Effects of carnosine, ankaferd and silver sulfadiazine on an experimental burn model; roles of Irisin and HSP70
  370. Effects of central fibroblast growth factor 21 and Irisin in anxiety-like behavior.
  371. Effects of central Irisin administration on the uncoupling proteins in rat brain
  372. Effects of chronic Irisin administration on body weight and reproductive organ weights in rats.
  373. Effects of Combined Exercise on Irisin, Body Composition and Glucose Metabolism in Obese Elderly Women with Type 2 Diabetes Mellitus
  374. Effects of concurrent training on Irisin and fibronectin type-III domain containing 5 (FNDC5) expression in visceral adipose tissue in type-2 diabetic rats
  375. Effects of delivery on maternal & neonatal Irisin levels in normal and preeclamptic pregnant women
  376. Effects of dietary macronutrient composition on FNDC5 and Irisin in mice skeletal muscle
  377. Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis
  378. Effects of Exercise on Serum Levels of Irisin in High School Girls
  379. Effects of exercise on the circulating concentrations of Irisin in healthy adult individuals: A review
  380. Effects of green tea extract supplementation and endurance training on Irisin, pro-inflammatory cytokines, and adiponectin concentrations in overweight middle-aged …
  381. Effects of high-intensity circuit training on muscle strength, Irisin, FGF-21, and adiponectin in obese female college students
  382. Effects of high-intensity resistance training on circulating levels of Irisin in healthy adults: A randomized controlled trial
  383. Effects of high-intensity treadmill training on timeliness and plasticity expression of Irisin in mice
  384. Effects of hippocampal microinjection of Irisin, an exercise-induced myokine, on spatial and passive avoidance learning and memory in male rats
  385. Effects of Hypnotherapy on Weight Loss and thus on Serum Leptin, Adiponectin, and Irisin Levels in Obese Patients
  386. Effects of Interval Training on Irisin and Insulin Resistance in Overweight Men
  387. Effects of intra-dentate gyrus microinjection of myokine Irisin on long-term potentiation in male rats
  388. Effects of intracerebroventricular administration of Irisin on the hypothalamus–pituitary–gonadal axis in male rats
  389. Effects of Irisin and exercise on metabolic parameters and reproductive hormone levels in high-fat diet-induced obese female mice
  390. Effects of Irisin compared with exercise on specific metabolic and obesity parameters in female mice with obesity
  391. Effects of Irisin on osteoblast apoptosis and osteoporosis in postmenopausal osteoporosis rats through upregulating Nrf2 and inhibiting NLRP3 …
  392. Effects of Irisin on proliferation, apoptosis, migration and invasion of human cholangiocarcinoma cell line Hucct-1
  393. Effects of Irisin on the differentiation and browning of human visceral white adipocytes
  394. Effects of Irisin on the dysfunction of blood–brain barrier in rats after focal cerebral ischemia/reperfusion
  395. Effects of Irisin on the Reproductive Parameters in High-Fat Diet-Induced Obese Male Rats
  396. Effects of lifestyle modification and metformin on Irisin and FGF 21 among HIV‐infected subjects with the metabolic syndrome
  397. Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo
  398. Effects of melatonin on lipid metabolism and circulating Irisin in diet‐induced obese Sprague‐Dawley rats
  399. Effects of melatonin on lipid metabolism and circulating Irisin in sprague-dawley rats with diet-induced obesity
  400. Effects of obesity, diabetes and exercise on Fndc5 gene expression and Irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies
  401. Effects of partial vascular occlusion on Irisin responses to loaded muscle contractions
  402. Effects of recombinant Irisin on body mass index, serum insulin, luteinizing hormone and testosterone levels in obese female BALB/c mice
  403. Effects of resveratrol, grape juice or red wine consumption Irisin levels and fibronectin type III domain containing protein 5 and uncoupoling protein gene …
  404. Effects of running a marathon on Irisin concentration in men aged over 50
  405. Effects of Short Term Metformin Treatment on Brown Adipose Tissue Activity and Plasma Irisin Levels in Women with Polycystic Ovary Syndrome: A …
  406. Effects of sprint interval exercise dose and sex on circulating Irisin and redox status markers in adolescent swimmers
  407. Effects of Strength Training on Serum Levels of Irisin and Myostatin Hormones, and Their Association with Lipid Profiles in Untrained Women
  408. Effects of swimming exercise on serum Irisin and bone FNDC5 in rat models of high-fat diet-induced osteoporosis
  409. Effects of the exercise‐inducible myokine Irisin on malignant and non‐malignant breast epithelial cell behavior in vitro
  410. Effects of whole-body cryotherapy on 25-hydroxyvitamin D, Irisin, myostatin, and interleukin-6 levels in healthy young men of different fitness levels
  411. Effects of whole-body cryotherapy on 25-hydroxyvitamin D, Irisin, myostatin, and interleukin-6 levels in healthy young men of different fitness levels
  412. Elevated circulating Irisin is associated with lower risk of insulin resistance: association and path analyses of obese Chinese adults
  413. Elevated circulating levels of Irisin and the effect of metformin treatment in women with polycystic ovary syndrome
  414. Elevated Irisin and alanine aminotransferase levels in hypothyroidism: role of oxidative stress?
  415. Elevated Irisin Expression in NASH Livers
  416. Elevated Serum Irisin Level is not Related to Metabolic and Anthropometric Parameters in Obese Children
  417. Elevated skeletal muscle Irisin precursor FNDC5 mRNA in obese OLETF rats
  418. Elevation in Serum Irisin Levels after a Single Bout of Exercise do not Modulate Resting Energy Expenditure and Diet-induced Thermogenesis in Healthy …
  419. ELSEVIER: Irisin in response to acute and chronic whole-body vibration exercise in humans
  420. Endurance Training Induced Irisin Increase Inhibited FTO Expression of Fatty Tissue in Obese Rats
  421. Endurance training-induced increase in circulating Irisin levels is associated with reduction of abdominal visceral fat in middle-aged and older adults
  422. Engineering Irisin for Understanding Its Benefits to Obesity
  423. Epicardial Fat Thickness in Metabolic Syndrome Metabolik Sendromda İrisin Düzeylerinin ve Epikardiyal Yağ Kalınlığının Değerlendirilmesi
  424. Evaluation of circulating Irisin levels in healthy young individuals after a single 100,000 IU vitamin D dose
  425. Evaluation of circulating Irisin levels in patients with never treated overt hyperthyrodisim
  426. Evaluation of cord blood Irisin levels in term newborns with small gestational age and appropriate gestational age
  427. Evaluation of correlations of plasma levels of oxytocin, omentin-1 and Irisin in diabetic and nondiabetic metabolic syndrome patients: a cross sectional study in …
  428. Evaluation of ghrelin, nesfatin-1 and Irisin levels of serum and brain after acute or chronic pentylenetetrazole administrations in rats using sodium valproate
  429. Evaluation of Irisin and visfatin levels in very low birth weight preterm newborns compared to full term newborns—A prospective cohort study
  430. Evaluation of Irisin levels in chronic heart failure with preserved or reduced ejection fraction
  431. Evaluation of Irisin, retinol-binding protein 4, and leptin serum levels as biomarkers of macrovascular complications involvement in Saudi type 2 diabetes mellitus. A …
  432. Evaluation of serum Irisin and creatine kinase levels in hypo and hyperthyroid rats
  433. EVALUATION OF SERUM Irisin AND CREATINE KINASE LEVELS IN HYPO-AND HYPERTHYROID RATS
  434. EVALUATION OF SERUM Irisin WITH LIPID PROFILE IN TYPE-2 DIABETIC PATIENTS IN SULAIMANI
  435. Evaluation of serum levels of Irisin and nesfatin-1 in patients with migraine without aura
  436. Evaluation of structural-functional changes of the left ventricular myocardium in patients with arterial hypertension and obesity by the level of Irisin
  437. Evaluation of structural-functional changes of the left ventricular myocardium in patients with arterial hypertension and obesity by the level of Irisin
  438. Evidence against a beneficial effect of Irisin in humans
  439. Excessive Irisin increases oxidative stress and apoptosis in murine heart
  440. Exenatide treatment increases serum Irisin levels in patients with obesity and newly diagnosed type 2 diabetes
  441. Exercise alleviates osteoporotic changes in glucocorticoids-induced osteoporosis in a rat model: a possible role of endogenous Irisin
  442. Exercise alleviates osteoporotic changes in glucocorticoids-induced osteoporosis in a rat model: a possible role of endogenous Irisin
  443. Exercise ameliorates emphysema of cigarette smoke-induced COPD in mice through the exercise-Irisin-Nrf2 axis
  444. Exercise enhances mitochondrial fission and mitophagy to improve myopathy following critical limb ischemia in elderly mice via the PGC1a/FNDC5/Irisin …
  445. Exercise hormone (Irisin)
  446. Exercise Hormone Irisin Mitigates Endothelial Barrier Dysfunction and Experimental Lung Injury
  447. Exercise hormone Irisin mitigates endothelial barrier dysfunction and microvascular leakage–related diseases
  448. Exercise improved cognitive impairment in aging mice via skeletal Irisin
  449. Exercise Induced Irisin Alleviates Type 1 Diabetic Nephropathy by Promoting Mitochondria Biogenesis and Function
  450. Exercise protein Irisin promotes angiogenesis in endothelial cells
  451. Exercise training increases cardiac, hepatic and circulating levels of brain-derived neurotrophic factor and Irisin in young and aged rats
  452. Exercise training with dietary restriction enhances circulating Irisin level associated with increasing endothelial progenitor cell number in obese adults: an …
  453. Exercise-induced circulating Irisin level is correlated with improved cardiac function in rats
  454. Exercise-induced Irisin in bone and systemic Irisin administration reveal new regulatory mechanisms of bone metabolism
  455. Exercise-induced Irisin response in adults: Effect of exercise-mode and age
  456. Exercise-induced Irisin secretion is independent of age or fitness level and increased Irisin may directly modulate muscle metabolism through AMPK activation
  457. Exercise-induced Irisin, the fat browning myokine, as a potential anticancer agent
  458. Exercise-induced myokine FNDC5/Irisin functions in cardiovascular protection and intracerebral retrieval of synaptic plasticity
  459. Exercise-linked FNDC5/Irisin rescues synaptic plasticity and memory defects in Alzheimer’s models
  460. Exercise-mimicking treatment fails to increase Fndc5 mRNA & Irisin secretion in primary human myotubes
  461. Exercise‐Induced Amelioration of Diet‐Induced Obesity and Diabetes is Not Regulated by Irisin
  462. Exercise‐induced Irisin release as a determinant of the metabolic response to exercise training in obese youth: the EXIT trial
  463. Exercise− A unique endogenous regulator of Irisin, BDNF, leptin and cortisol against depression
  464. Exogenous Treatment With Irisin Improves Bone Formation in Inflammatory Bowel Disease
  465. EXPRESSION OF Irisin AND ITS RELATION WITH ANTHROPOMETRIC AND BIOCHEMICAL PARAMETERS IN DIABETES MELLITUS TYPE II PATIENTS
  466. Expression of Irisin/FNDC5 in cancer cells and stromal fibroblasts of non-small cell lung cancer
  467. Expression of the Irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure
  468. Expression, purification and biological characterisation of recombinant human Irisin (12.5 kDa)
  469. Expressions of Irisin and urotensin II and their relationships with blood pressure in patients with preeclampsia
  470. Factors associated with circulating concentrations of Irisin in the general population cohort of the ABCD study
  471. Factors associated with increased Irisin levels in the type 1 diabetes mellitus
  472. Fasting insulin and alanine amino transferase, but not FGF21, were independent parameters related with Irisin increment after intensive aerobic exercising
  473. FGF21, Irisin and other novel players in endocrine metabolic regulation
  474. Fibroblast growth factor 21, adiponectin, and Irisin as markers of unfavorable metabolic features in 12-year-old children
  475. Fibronectin Type III Domain–Containing Protein 5 rs3480 A> G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
  476. First-trimester Irisin and fetuin-a concentration in predicting macrosomia
  477. Fndc4, a highly identical ortholog of Irisin binds and activates a novel orphan receptor G-protein coupled receptor
  478. FNDC5 (Irisin) gene and exceptional longevity: a functional replication study with rs16835198 and rs726344 SNPs
  479. FNDC5 and Irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to …
  480. FNDC5 expression and circulating Irisin levels are modified by diet and hormonal conditions in hypothalamus, adipose tissue and muscle
  481. FNDC5 Gene Expression and Irisin Protein Level of Visceral Fat Tissue after Eight Weeks of Resistance Training in Type 2 Diabetic Rats
  482. FNDC5 overexpression and Irisin ameliorate glucose/lipid metabolic derangements and enhance lipolysis in obesity
  483. FNDC5/Irisin counteracts lipotoxic-induced apoptosis in hypoxic H9c2 cells
  484. FNDC5/Irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction
  485. FNDC5/Irisin inhibits pathological cardiac hypertrophy
  486. FNDC5/Irisin is expressed and regulated differently in human periodontal ligament cells, dental pulp stem cells and osteoblasts
  487. FNDC5/Irisin is not only a myokine but also an adipokine
  488. FNDC5/Irisin System in Neuroinflammation and Neurodegenerative Diseases: Update and Novel Perspective
  489. FNDC5/Irisin–their role in the nervous system and as a mediator for beneficial effects of exercise on the brain
  490. FNDC5/Irisin, a molecular target for boosting reward-related learning and motivation
  491. FNDC5/Irisin: a new protagonist in acute brain injury
  492. Frailty of the elderly in orthopaedic surgery and body composition changes: the musculoskeletal crosstalk through Irisin.
  493. Free androgen index and Irisin in polycystic ovary syndrome
  494. FRI0078 SERUM Irisin LEVEL IN RHEUMATOID ARTHRITIS PATIENTS: ITS RELATIONSHIP TO DISEASE ACTIVITY AND CARDIOVASCULAR …
  495. From white to brown fat through the PGC-1α-dependent myokine Irisin: implications for diabetes and obesity
  496. Gene expression of FNDC5 and related genes in gluteal subcutaneous adipose tissue and plasma Irisin levels after acute inactivity
  497. Grape pomace extract supplementation activates FNDC5/Irisin in muscle and promotes white adipose browning in rats fed a high-fat diet
  498. Greek goddess or Greek myth: the effects of exercise on Irisin/FNDC5 in humans
  499. Green cardamom supplementation improves serum Irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a …
  500. Growth hormone treatment increases plasma Irisin concentration in patients with turner syndrome
  501. GW26-e4495 A study of the association of plasma Irisin levels and coronary artery diseases
  502. GW28-e0562 Irisin Deficiency Disrupts Glucose Utilization and Sensitizes the Heart to Ischemia/Reperfusion Injury
  503. GW29-e1228 Irisin protects cardiomyocytes against ischemia/reperfusion-injury via attenuating endoplasmic reticulum stress
  504. Habitual physical activity is associated with circulating Irisin in healthy controls but not in subjects with diabetes mellitus type 2
  505. HEALTH RELATED INFLUENCE OF EXERCISE INDUCED Irisin SECRETION
  506. Hepatoprotective effects of silymarin on liver injury via Irisin upregulation and oxidative stress reduction in rats with type 2 diabetes
  507. High circulating Irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects
  508. High dose simvastatin and rosuvastatin impair cognitive abilities of healthy rats via decreasing hippocampal neurotrophins and Irisin
  509. High Irisin levels are associated with better glycemic control and bone health in children with Type 1 diabetes
  510. High Irisin levels in nondiabetic HIV‐infected males are associated with insulin resistance, nonalcoholic fatty liver disease, and subclinical atherosclerosis
  511. High Irisin levels in overweight/obese children and its positive correlation with metabolic profile, blood pressure, and endothelial progenitor cells
  512. High serum Irisin level as an independent predictor of diabetes mellitus: a longitudinal population-based study
  513. High-intensity exercise causes greater Irisin response compared with low-intensity exercise under similar energy consumption
  514. High-intensity interval training improved fasting blood glucose and lipid profiles in type 2 diabetic rats more than endurance training; possible involvement of Irisin and …
  515. Higher baseline Irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects
  516. Higher baseline serum Irisin decreases risk for body mass index increment in Chinese populations: a 3.2-year cohort study
  517. Higher circulating Irisin levels in patients with polycystic ovary syndrome: a meta-analysis
  518. Hindlimb unloading causes regional loading-dependent changes in osteocyte inflammatory cytokines that are modulated by exogenous Irisin treatment
  519. Hippocampal and Prefrontal Cortical Brain Tissue Levels of Irisin and GDF15 Receptor Subunits in Children
  520. Hippocampal injection of the exercise-induced myokine Irisin suppresses acute stress-induced neurobehavioral impairment in a sex-dependent manner.
  521. How Does an Intensive Exercise Training Changes Irisin and Heat Shock Protein 70 Levels in Trained Males?
  522. http://bjas. bu. edu. eg Assessment of Insulin Resistance and Serum Levels of Irisin in Patients with Idiopathic
  523. Hypertension and beyond—does circulating Irisin matter?
  524. Hypothesis: Irisin is a metabolic trigger for the activation of the neurohormonal axis governing puberty onset
  525. Hypoxic training increases the concentration of serum Irisin and reduces weight in diet-induced obese rats
  526. I scream, you scream, we all scream for Irisin
  527. Icariin induces Irisin/FNDC5 expression in C2C12 cells via the AMPK pathway
  528. ID: 228: Irisin–A newly discovered adipomiokine–Impairs growth and progression of breast cancer MDA-MB-231 cell line
  529. Identification of immunohistochemical localization of Irisin in the dwarf hamster (Phodopus roborovskii) tissues
  530. Identification of Irisin as a therapeutic agent that inhibits oxidative stress and fibrosis in a murine model of chronic pancreatitis
  531. Identification of Irisin immunoreactivity in porcupine (Hystrix cristata) adrenal glands and kidneys
  532. Immunohistochemical distribution of Irisin in the lung and tongue of Porcupine (Hystrix cristata)
  533. Immunohistochemical localization of Irisin in mole rats (Spalax leucodon)
  534. Immunohistochemical localization of Irisin in skin, eye, and thyroid and pineal glands of the crested porcupine (Hystrix cristata)
  535. Immunostaining characteristics of Irisin in benign and malignant renal cancers
  536. Impact of exercise induced skeletal muscle strain on energy regulatory hormones of Irisin and nesfatin-1 in sedentary males
  537. Impact of Maternal Chronodisruption on Female Offspring Puberty. A Role of Kisspeptin and Irisin
  538. Impact of supervised exercise training on pulmonary function parameters, exercise capacity and Irisin Biomarker in Interstitial lung disease patients
  539. Impact of testosterone treatment on circulating Irisin in men with late-onset hypogonadism and metabolic syndrome
  540. Impact of vigorous-intensity physical activity on body composition parameters, lipid profile markers, and Irisin levels in adolescents: a cross-sectional study
  541. Impact of vitamin D correction on circulating Irisin: a 12 month interventional study
  542. Impacts of rat hindlimb Fndc5/Irisin overexpression on muscle and adipose tissue metabolism
  543. Implication of circulating Irisin levels with brown adipose tissue and sarcopenia in humans
  544. Implication of the myokine Irisin in maternal energy homeostasis in pregnancies with abnormal fetal growth
  545. Implications of circulating Irisin and Fabp4 levels in patients with polycystic ovary syndrome
  546. Improved Insulin Sensitivity and Irisin after a Dietary Weight-Lowering Program in Obese, Otherwise Healthy Subjects
  547. In Addition to Poor Glycemic Control, a High Level of Irisin in the Plasma Portends Early Cognitive Deficits Clinically in Chinese Patients With Type 2 Diabetes …
  548. Inconsistency in circulating Irisin levels: what is really happening
  549. Increased 24-hour ad libitum food intake is associated with lower plasma Irisin concentrations the following morning in adult humans
  550. Increased circulating levels of Irisin are associated with cardiovascular risk factors in subjects with acromegaly
  551. Increased expression of meteorin-like hormone in type 2 diabetes and obesity and its association with Irisin
  552. Increased FNDC5/Irisin expression in human hepatocellular carcinoma
  553. Increased Irisin abundance in muscle and blood circulation after treadmill exercise in mice
  554. INCREASED Irisin CONCENTRATIONS IN PATIENTS WITH CRIMEAN-CONGO HEMORRAGIC FEVER
  555. Increased Irisin versus reduced fibroblast growth factor1 (FGF1) in relation to adiposity, atherogenicity and hematological indices in metabolic syndrome patients with …
  556. Increased level of serum Irisin concentration and its regulation by hyperinsulinemia in women with polycystic ovary syndrome
  557. Increased levels of Irisin in people with long‐standing Type 1 diabetes
  558. Inflammation‐induced lymphatic architecture and bone turnover changes are ameliorated by Irisin treatment in chronic inflammatory bowel disease
  559. Influence of endurance and sprinting exercise on plasma adiponectin, leptin and Irisin concentrations in racing Greyhounds and sled dogs
  560. Influence of Irisin on diet-induced metabolic syndrome in experimental rat model
  561. Inhibition of myostatin in mice improves insulin sensitivity via Irisin-mediated cross talk between muscle and adipose tissues
  562. Insulin Regulates Circulating Omen-tin, Fatty Acid Binding Protein-4 and Chemerin, but not Irisin in Man
  563. Integrin-Ligand Interactions in Inflammation, Cancer, and Metabolic Disease: Insights Into the Multifaceted Roles of an Emerging Ligand Irisin
  564. Interleukin-15 and Irisin serum concentrations are not related to cardiometabolic risk factors in patients with type 2 diabetes from Korea and Germany
  565. Interventional changes of thyroid hormone levels do not affect circulating Irisin levels in humans
  566. Investigating a potential role for Irisin as a biomarker in the early detection of Alzheimer’s disease
  567. Investigation of Irisin Level in Brucella Patients
  568. Investigation of the expression of Irisin and some cachectic factors in mice with experimentally induced gastric cancer
  569. Investigation of the Irisin, preptin and adropin levels in the blood serum of Alburnus tarichi
  570. Involvement of the p62/Nrf2/HO-1 pathway in the browning effect of Irisin in 3T3-L1 adipocytes
  571. Irisin
  572. Irisin a novel metabolic biomarker: present knowledge and future directions
  573. Irisin activates Opa1-induced mitophagy to protect cardiomyocytes against apoptosis following myocardial infarction
  574. Irisin acts as a regulator of macrophages host defense
  575. Irisin alleviates advanced glycation end products-induced inflammation and endothelial dysfunction via inhibiting ROS-NLRP3 inflammasome signaling
  576. Irisin alleviates liver ischemia-reperfusion injury by inhibiting excessive mitochondrial fission, promoting mitochondrial biogenesis and decreasing oxidative …
  577. Irisin alleviates LPS-induced liver injury and inflammation through inhibition of NLRP3 inflammasome and NF-κB signaling
  578. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway
  579. Irisin alleviates pulmonary epithelial barrier dysfunction in sepsis-induced acute lung injury via activation of AMPK/SIRT1 pathways
  580. Irisin alleviates renal injury caused by sepsis via the NF‐κB signaling pathway
  581. Irisin ameliorates angiotensin II‐induced cardiomyocyte apoptosis through autophagy
  582. Irisin ameliorates bone loss in ovariectomized mice
  583. Irisin ameliorates depressive-like behaviors in rats by regulating energy metabolism
  584. Irisin ameliorates endoplasmic reticulum stress and liver fibrosis through inhibiting PERK-mediated destabilization of HNRNPA1 in hepatic stellate cells
  585. Irisin ameliorates glucolipotoxicity-associated β-Cell dysfunction and apoptosis via AMPK signaling and anti-inflammatory actions
  586. Irisin ameliorates hepatic glucose/lipid metabolism and enhances cell survival in insulin-resistant human HepG2 cells through adenosine monophosphate-activated …
  587. Irisin ameliorates high glucose‐induced cardiomyocytes injury via AMPK/mTOR signal pathway
  588. Irisin Ameliorates Hypoxia/Reoxygenation-Induced Inflammation and Apoptosis in PC12 Cells by Inhibiting TLR4/MYD88 Signaling Pathway.
  589. Irisin ameliorates hypoxia/reoxygenation-induced injury through modulation of histone deacetylase 4
  590. Irisin ameliorates septic cardiomyopathy via inhibiting DRP1-related mitochondrial fission and normalizing the JNK-LATS2 signaling pathway
  591. Irisin ameliorates the postoperative depressive-like behavior by reducing the surface expression of epidermal growth factor receptor in mice
  592. Irisin and Abdominal Obesity in Preschool Age
  593. Irisin and Autophagy: First Update
  594. Irisin and BDNF serum levels and behavioral disturbances in Alzheimer’s disease
  595. Irisin and bone: from preclinical studies to the evaluation of its circulating levels in different populations of human subjects
  596. Irisin and cardiovascular risk
  597. Irisin and chemerin levels in patients with type 2 diabetes mellitus
  598. Irisin and exercise to lose weight
  599. Irisin and exercise training in humans–results from a randomized controlled training trial
  600. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans
  601. Irisin and fibronectin type III domain-containing 5 responses to exercise in different environmental conditions
  602. Irisin and FNDC5 in retrospect: an exercise hormone or a transmembrane receptor?
  603. Irisin and FNDC5 Responses to Exercise in Different Environmental Conditions
  604. Irisin and FNDC5: effects of 12-week strength training, and relations to muscle phenotype and body mass composition in untrained women
  605. Irisin and inflammatory cytokines in elite male rowers: adaptation to volume-extended training period
  606. Irisin AND ITS EFFECTS ON CARDIOMETABOLIC DISEASES IN PHYSICAL CONDITIONING AND TREATMENT OF COVID-19
  607. Irisin and its relation to insulin resistance and puberty in obese children: a longitudinal analysis
  608. Irisin and kidney disease; new concepts
  609. Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: a cross sectional and a prospective case-control study nested in the Normative …
  610. Irisin and markers of metabolic derangement in non-diabetic Caucasian subjects with stage I-II obesity during early aging
  611. Irisin and metabolic disorders
  612. Irisin and musculoskeletal health
  613. Irisin and myonectin regulation in the insulin resistant muscle: implications to adipose tissue: muscle crosstalk
  614. Irisin and myostatin levels in patients with Graves’ disease
  615. Irisin and myostatin responses to acute high-intensity interval exercise in humans
  616. Irisin and testosterone in men with metabolic syndrome
  617. Irisin and the metabolic phenotype of adults with Prader-Willi syndrome
  618. Irisin and the therapeutic benefits of exercise
  619. Irisin and troponin I expression in dialysis patients submitted to remote ischemic preconditioning: a pilot study
  620. Irisin and Vascular Inflammation: Beneficial Effects of a Healthy Lifestyle Around and Beyond Physical Activity.
  621. Irisin and Visfatin Predicts Severity of Diabetic Nephropathy
  622. Irisin and volume overload are associated with protein energy wasting in peritoneal dialysis patients
  623. Irisin as a Biomarker for Insulin Resistance in Polycystic Ovary Syndrome: a Meta-analysis
  624. Irisin as a central regulator in energy homeostasis?
  625. Irisin AS A MARKER OF INSULIN RESISTANCE IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY
  626. Irisin as a mediator between obesity and vascular inflammation in Chinese children and adolescents
  627. Irisin as a multifunctional protein: Implications for health and certain diseases
  628. Irisin as a muscle-derived hormone stimulating thermogenesis–a critical update
  629. Irisin as a new marker for the early diagnosis of low-traumatic fractures in rheumatoid arthritis.
  630. Irisin as a Novel Marker for Insulin Resistance in Iraqi Women with Polycystic Ovary Syndrome Before and After Metformin Therapy
  631. Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects
  632. Irisin as a regulator of bone and glucose metabolism.
  633. Irisin as an early marker for predicting gestational diabetes mellitus: a prospective study
  634. Irisin as an exercise-stimulated hormone binding crosstalk between organs
  635. Irisin attenuates angiotensin II-induced cardiac fibrosis via Nrf2 mediated inhibition of ROS/TGFβ1/Smad2/3 signaling axis
  636. Irisin attenuates H2O2-induced apoptosis in cardiomyocytes via microRNA-19b/AKT/mTOR signaling pathway
  637. Irisin Attenuates High Fat Diet-Induced Cardiac Dysfunction and Metabolic Disorder Through the Hdac4 Pathway
  638. Irisin attenuates intestinal injury, oxidative and endoplasmic reticulum stress in mice with L-arginine-induced acute pancreatitis
  639. Irisin attenuates myocardial ischemia/reperfusion injury and improves mitochondrial function through AMPK pathway in diabetic mice
  640. Irisin attenuates myocardial ischemia/reperfusion‐induced cardiac dysfunction by regulating ER‐mitochondria interaction through a mitochondrial ubiquitin ligase …
  641. Irisin attenuates neuroinflammation and prevents the memory and cognitive deterioration in streptozotocin-induced diabetic mice
  642. Irisin attenuates osteoarthritis by inhibiting apoptosis of osteocytes through activating erk signaling pathway
  643. Irisin attenuates oxidized low‐density lipoprotein impaired angiogenesis through AKT/mTOR/S6K1/Nrf2 pathway
  644. Irisin boosts bone mass
  645. Irisin COMPROMISES INFRAPATELLAR ADIPOGENESIS AND KNEE OSTEOARTHRITIS
  646. Irisin concentration in infant formulas and breast milk.
  647. Irisin Contributes to Neuroprotection by Promoting Mitochondrial Biogenesis After Experimental Subarachnoid Hemorrhage
  648. Irisin contributes to the hepatoprotection of dexmedetomidine during intestinal ischemia/reperfusion
  649. Irisin controls growth, intracellular Ca 2+ signals, and mitochondrial thermogenesis in cardiomyoblasts
  650. Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts
  651. Irisin counteracts high glucose and fatty acid-induced cytotoxicity by preserving the AMPK-insulin receptor signaling axis in C2C12 myoblasts
  652. Irisin deficiency disturbs bone metabolism
  653. Irisin Directly Affects Cardiac Glucose Oxidation and Contractile Function
  654. Irisin directly stimulates osteoclastogenesis and bone resorption in vitro and in vivo
  655. Irisin does not mediate resistance training-induced alterations in resting metabolic rate.
  656. Irisin EFFECTS ON CATABOLIC AND PRO-INFLAMMATORY GENES IN HUMAN OSTEOARTHRITIC CHONDROCYTES
  657. Irisin Enhances Cardiac Progenitor Cell-induced Cardiac Repair in the Infarcted Heart
  658. Irisin enhances doxorubicin-induced cell apoptosis in pancreatic cancer by inhibiting the PI3K/AKT/NF-κB pathway
  659. Irisin enhances osteoblast differentiation in vitro
  660. Irisin Enhances Osteoblast Differentiation In Vitro
  661. Irisin ERKs the fat
  662. Irisin ERKs the Fat. Diabetes 2014; 63: 3812383
  663. Irisin evokes bradycardia by activating cardiac‐projecting neurons of nucleus ambiguus
  664. Irisin exerts a therapeutic effect against myocardial infarction via promoting angiogenesis
  665. Irisin exerts dual effects on browning and adipogenesis of human white adipocytes
  666. Irisin exerts inhibitory effect on adipogenesis through regulation of Wnt signaling
  667. Irisin exerts neuroprotective effects on cultured neurons by regulating astrocytes
  668. Irisin functions to inhibit malignant growth of human pancreatic cancer cells via downregulation of the PI3K/AKT signaling pathway
  669. Irisin Gene Delivery Ameliorates Burn-Induced Sensory and Motor Neuropathy
  670. Irisin Gene Polymorphism Rs3480 and Rs1746661and Obesity in Egyptian Populations
  671. Irisin has no effect on lipolysis in 3T3-L1 adipocytes or fatty acid metabolism in HepG2 hepatocytes
  672. Irisin immunohistochemistry in gastrointestinal system cancers
  673. Irisin immunostaining characteristics of breast and ovarian cancer cells
  674. Irisin improves autophagy of aged hepatocytes via increasing telomerase activity in liver injury
  675. Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway
  676. Irisin improves endothelial function in type 2 diabetes through reducing oxidative/nitrative stresses
  677. Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway
  678. Irisin improves insulin resistance by inhibiting autophagy through the PI3K/Akt pathway in H9c2 cells
  679. Irisin Improves Myocardial Performance and Attenuates Insulin Resistance in Spontaneous Mutation (Leprdb) Mice
  680. Irisin improves perivascular adipose tissue dysfunction via regulation of the heme oxygenase-1/adiponectin axis in diet-induced obese mice
  681. Irisin Improving Atherosclerosis Condition in ApoE-/-Diabetes Mellitus Mice
  682. Irisin in Adolescent Type 1 Diabetic Patients and its Relation to Diabetes Control and Atherosclerosis
  683. Irisin in blood increases transiently after single sessions of intense endurance exercise and heavy strength training
  684. Irisin in coronary bypass surgery
  685. Irisin in elderly people with hypertension, diabetes mellitus type 2, and overweight and obesity
  686. Irisin in goldfish (Carassius auratus): Effects of Irisin injections on feeding behavior and expression of appetite regulators, uncoupling proteins and lipoprotein lipase …
  687. Irisin IN HEALTHY YOUNG INDIVIDUALS: ASSOCIATION WITH GENDER, EXERCISE, DIET AND BODY COMPOSITION: DAY-NIGHT RHYTHM AND THE EFFECT …
  688. Irisin in humans: recent advances and questions for future research
  689. Irisin in idiopathic foetal growth restriction
  690. Irisin in Liver Cirrhosis
  691. Irisin in metabolic diseases
  692. Irisin in patients with nonalcoholic fatty liver disease
  693. Irisin in response to acute and chronic whole-body vibration exercise in humans
  694. Irisin in response to exercise in humans with and without metabolic syndrome
  695. Irisin in response to exercise in humans with and without metabolic syndrome
  696. Irisin in the glucose continuum
  697. Irisin in the primate hypothalamus and its effect on GnRH in vitro
  698. Irisin increased the number and improved the function of endothelial progenitor cells in diabetes mellitus mice
  699. Irisin increases the expression of anorexigenic and neurotrophic genes in mouse brain
  700. Irisin induces angiogenesis in human umbilical vein endothelial cells in vitro and in zebrafish embryos in vivo via activation of the ERK signaling pathway
  701. Irisin induces trophoblast differentiation via AMPK activation in the human placenta
  702. Irisin inhibition of growth hormone secretion in cultured tilapia pituitary cells
  703. Irisin Inhibits Atherosclerosis by Promoting Endothelial Proliferation Through micro RNA 126‐5p
  704. Irisin inhibits hepatic cholesterol synthesis via AMPK-SREBP2 signaling
  705. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes
  706. Irisin inhibits high glucose‐induced endothelial‐to‐mesenchymal transition and exerts a dose‐dependent bidirectional effect on diabetic cardiomyopathy
  707. Irisin inhibits osteocyte apoptosis by activating the Erk signaling pathway in vitro and attenuates ALCT-induced osteoarthritis in mice
  708. Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway
  709. Irisin injected mice display increased tibial cortical mineral density and polar moment of inertia
  710. Irisin interaction with adipose tissue secretions by exercise training and flaxseed oil supplement
  711. Irisin is a biomarker for metabolic syndrome in prepubertal children
  712. Irisin Is a Positive Regulator for Ferroptosis in Pancreatic Cancer
  713. Irisin is a pro-myogenic factor that induces skeletal muscle hypertrophy and rescues denervation-induced atrophy
  714. Irisin is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy
  715. Irisin is associated with clinical outcomes and up-regulated by long-acting anticholinergics in COPD
  716. Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity
  717. Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
  718. Irisin is associated with urotensin II and protein energy wasting in hemodialysis patients
  719. Irisin is controlled by farnesoid X receptor and regulates cholesterol homeostasis
  720. Irisin is elevated in skeletal muscle and serum of mice immediately after acute exercise
  721. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance
  722. Irisin is expressed by undifferentiated spermatogonia and modulates gene expression in organotypic primate testis cultures
  723. Irisin is induced in renal ischemia-reperfusion to protect against tubular cell injury via suppressing p53
  724. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults
  725. Irisin is more strongly predicted by muscle oxidative potential than adiposity in non-diabetic men
  726. Irisin is present in α cells and decreases islet blood flow
  727. Irisin is regulated by CAR in liver and is a mediator of hepatic glucose and lipid metabolism
  728. Irisin is weakly associated with usual physical activity in young overweight women
  729. Irisin is weakly associated with usual physical activity in young overweight women La Irisina se asocia débilmente con la actividad física habitual en mujeres jóvenes …
  730. Irisin level and neonatal birthweight: A systematic review and meta-analysis
  731. Irisin level in type 2 diabetic patients and its relation to glycemic control and diabetic complications
  732. Irisin levels are associated with exercise level, pain and function in patients with knee osteoarthritis
  733. Irisin levels are associated with urotensin II levels in diabetic patients
  734. Irisin levels are lower in young amenorrheic athletes compared with eumenorrheic athletes and non-athletes and are associated with bone density and …
  735. Irisin levels are not affected by physical activity in patients with anorexia nervosa
  736. Irisin levels are not associated to resistance training-induced alterations in body mass composition in older untrained women with and without obesity
  737. Irisin levels before and after physical activity among school‐age children with different BMI: A direct relation with leptin
  738. Irisin levels correlate with bone mineral density in soccer players.
  739. Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass
  740. Irisin levels during pregnancy and changes associated with the development of preeclampsia
  741. Irisin levels in genetic and essential obesity: Clues for a potential dual role
  742. Irisin levels in genetic and essential obesity: clues for a potential dual role
  743. Irisin levels in LMNA-associated partial lipodystrophies
  744. Irisin levels in LMNA-mutated lipodystrophic syndromes
  745. Irisin levels in relation to metabolic and liver functions in Egyptian patients with metabolic syndrome
  746. Irisin levels in the progression of diabetes in sedentary women
  747. Irisin levels increase after treatment in patients with newly diagnosed Hashimoto thyroiditis
  748. Irisin Levels Increases After Treatment in Patients with Newly Diagnosed Hashimoto Thyroiditis
  749. Irisin Levels Related to Glycosylated Hemoglobin in Type 2 Diabetic Obese Women
  750. Irisin lowers blood pressure by activating the Nrf2 signaling pathway in the hypothalamic paraventricular nucleus of spontaneously hypertensive rats
  751. Irisin lowers blood pressure by improvement of endothelial dysfunction via AMPK‐Akt‐eNOS‐NO pathway in the spontaneously hypertensive rat
  752. Irisin maternal plasma and cord blood levels in mothers with spontaneous preterm and term delivery
  753. Irisin may have a role in pubertal development and regulation of reproductive function in rats
  754. Irisin mediates effects on bone and fat via αV integrin receptors
  755. Irisin mediates effects on bone and fat via αv integrin receptors
  756. Irisin Mediates Effects on Bone via αV Integrin Receptors
  757. Irisin Mitigates Oxidative Stress, Chondrocyte Dysfunction and Osteoarthritis Development through Regulating Mitochondrial Integrity and Autophagy
  758. Irisin modulates genes associated with severe coronavirus disease (COVID-19) outcome in human subcutaneous adipocytes cell culture
  759. Irisin modulates the association of interleukin-17A with the presence of non-proliferative diabetic retinopathy in patients with type 2 diabetes
  760. Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans
  761. Irisin peptide is myokine, anti-obesity and anti-lipidemic factor
  762. Irisin peptide protects brain against ischemic injury through reducing apoptosis and enhancing BDNF in a rodent model of stroke
  763. Irisin physiology, oxidative stress, and thyroid dysfunction: what next?
  764. Irisin plasma concentration in PCOS and healthy subjects is related to body adipose content
  765. Irisin plasma concentration in PCOS and healthy subjects is related to body fat content and android fat distribution
  766. Irisin plasma level is connected with the android adipose tissue deposit
  767. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury
  768. Irisin plays an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, China
  769. Irisin pre-treatment promotes multi-territory perforator flap survival in rats: An experimental study
  770. Irisin pretreatment ameliorates intestinal ischemia/reperfusion injury in mice through activation of the Nrf2 pathway
  771. Irisin pretreatment protects kidneys against acute kidney injury induced by ischemia/reperfusion via upregulating the expression of uncoupling protein 2
  772. Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice
  773. Irisin prevents dexamethasone-induced atrophy in C2C12 myotubes
  774. Irisin prevents disuse‐induced osteocyte apoptosis
  775. Irisin prevents microgravity‐induced impairment of osteoblast differentiation in vitro during the space flight CRS‐14 mission
  776. Irisin promotes C2C12 myoblast proliferation via ERK-dependent CCL7 upregulation
  777. Irisin promotes cardiac progenitor cell‐induced myocardial repair and functional improvement in infarcted heart
  778. Irisin promotes cementoblast differentiation via p38 MAPK pathway
  779. Irisin PROMOTES EXERCISE ENHANCEMENT OF COGNITIVE FUNCTIONS IN OBESE EGYPTIAN WOMEN دور الأيريسين في تحسين بعض الوظائف المعرفيةالناتج …
  780. Irisin promotes growth, migration and matrix formation in human periodontal ligament cells
  781. Irisin promotes human umbilical vein endothelial cell proliferation through the ERK signaling pathway and partly suppresses high glucose-induced apoptosis
  782. Irisin promotes odontogenic differentiation and angiogenic potential in human dental pulp cells
  783. Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways
  784. Irisin promotes osteogenic differentiation of bone marrow mesenchymal stem cells by activating autophagy via the Wnt//β-catenin signal pathway
  785. Irisin promotes proliferation but inhibits differentiation in osteoclast precursor cells
  786. Irisin protect the Dopaminergic neurons of the Substantia nigra in the rat model of Parkinson’s disease
  787. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice
  788. Irisin Protects Against Hind Limb Ischemia Reperfusion Injury
  789. Irisin Protects Against Hypoxia and Reoxygenation Injury Through Hdac4
  790. Irisin Protects Against Motor Dysfunction of Rats with Spinal Cord Injury via Adenosine 5′-Monophosphate (AMP)-Activated Protein Kinase-Nuclear Factor …
  791. Irisin protects against neuronal injury induced by oxygen-glucose deprivation in part depends on the inhibition of ROS-NLRP3 inflammatory signaling pathway
  792. Irisin protects brain against ischemia/reperfusion injury through suppressing TLR4/MyD88 pathway
  793. Irisin protects heart against ischemia-reperfusion injury through a SOD2-dependent mitochondria mechanism
  794. Irisin protects macrophages from oxidized low density lipoprotein-induced apoptosis by inhibiting the endoplasmic reticulum stress pathway
  795. Irisin protects mitochondria function during pulmonary ischemia/reperfusion injury
  796. Irisin Protects the Heart Against Myocardial Ischemia and Reperfusion Injury
  797. Irisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson’s disease
  798. Irisin receptor in osteocytes identified
  799. Irisin recovers osteoarthritic chondrocytes in vitro
  800. Irisin recovers osteoarthritic chondrocytes: a muscle-cartilage cross-talk boosted by physical activity
  801. Irisin recovers osteoarthritic chondrocytes: a muscle-cartilage cross-talk boosted by physical activity
  802. Irisin Reduces the Metabolic Rate of Beige Adipocytes
  803. Irisin regulates cardiac physiology in zebrafish
  804. Irisin regulates heme oxygenase-1/adiponectin axis in perivascular adipose tissue and improves endothelial dysfunction in diet-induced obese mice
  805. Irisin regulates the expression of BDNF and glycometabolism in diabetic rats
  806. Irisin Regulates the Functions of Hepatic Stellate Cells
  807. Irisin relaxes mouse mesenteric arteries through endothelium-dependent and endothelium-independent mechanisms
  808. Irisin response to downhill running exercise in humans
  809. Irisin response to exercise training in adults and its effect on the regulation of C2C12 cell proliferation and differentiation
  810. Irisin response to two types of exercise training in type 2 diabetic male rats
  811. Irisin reverses insulin resistance in C2C12 cells via the p38-MAPK-PGC-1α pathway
  812. Irisin reverses intestinal epithelial barrier dysfunction during intestinal injury via binding to the integrin αVβ5 receptor
  813. Irisin reverses platelet derived growth factor-BB-induced vascular smooth muscle cells phenotype modulation through STAT3 signaling pathway
  814. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway
  815. Irisin serum levels are positively correlated with bone mineral status in a population of healthy children
  816. Irisin serum levels in metabolic syndrome patients treated with three different diets: a post-hoc analysis from a randomized controlled clinical trial
  817. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling
  818. Irisin stimulates cell proliferation and invasion by targeting the PI3K/AKT pathway in human hepatocellular carcinoma
  819. Irisin stimulates gonadotropins gene expression in tilapia (Oreochromis niloticus) pituitary cells
  820. Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans
  821. Irisin Stimulates Osteoclast Differentiation and Function
  822. Irisin stimulates the secretion of hyaluronic acid by airway smooth muscle cells from patients with chronic obstructive pulmonary disease
  823. Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition
  824. Irisin Treatment during Chronic Inflammatory Bowel Disease in an Rodent Model Improves Bone Formation Rate
  825. Irisin treatment improves healing of dystrophic skeletal muscle
  826. İrisin ve Metabolik Etkileri
  827. Irisin vs. Treadmill exercise in post myocardial infarction cardiac rehabilitation in rats
  828. Irisin 对 2 型糖尿病小鼠血糖的影响及机制
  829. Irisin–a new mediator of energy homeostasis
  830. Irisin-‘new kid on the block in energy regulation’?
  831. Irisin-a myokine potentially bridging muscle and fat tissue in cachexia.
  832. Irisin-encoding gene (FNDC5) variant is associated with changes in blood pressure and lipid profile in type 2 diabetic women but not in men
  833. Irisin-evidence for benefits resulting from physical activity
  834. Irisin-immunoreactivity in neural and non-neural cells of the rodent
  835. Irisin-mediated protective effect on LPS-induced acute lung injury via suppressing inflammation and apoptosis of alveolar epithelial cells
  836. Irisin-newly discovered adipo-myokine and its association with thyroid function-preliminary study
  837. Irisin-processor gene: molecular structure, expressive regulation, biological functions and the associations with skeletal muscle fiber types.
  838. Irisin–a myth rather than an exercise-inducible myokine
  839. Irisin–A potential contributor of insulin resistance in kidney failure
  840. Irisin—behind the benefits of exercise
  841. Irisin, a link among fatty liver disease, physical inactivity and insulin resistance
  842. Irisin, a newly discovered myokine, is a novel biomarker associated with physical activity in patients with chronic obstructive pulmonary disease
  843. Irisin, a novel hormone and exercise intensity in young healthy subjects
  844. Irisin, a Novel Hormone, and Its Response to Increasing Exercise Intensity in Young Healthy Subjects
  845. Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients
  846. Irisin, a novel myokine responsible for exercise induced browning of white adipose tissue
  847. Irisin, a novel myokine, regulates glucose uptake in skeletal muscle cells via AMPK
  848. Irisin, a novel myokine: potential role in obesity and diabetes
  849. Irisin, a unique non-inflammatory myokine in stimulating skeletal muscle metabolism
  850. Irisin, an exercise myokine, potently suppresses tumor proliferation, invasion, and growth in glioma
  851. Irisin, an exercise‐induced myokine as a metabolic regulator: an updated narrative review
  852. Irisin, leptin and adiponectin levels are reduced significantly during fasting
  853. Irisin, light my fire
  854. Irisin, physical activity and fitness status in healthy humans: No association under resting conditions in a cross-sectional study
  855. Irisin, Recombinant (Human, Mouse, Rat, Canine)
  856. Irisin, Resistin and 25-Hydroxyvitamin D in Iraqi Obese and Non-Obese Type 2 Diabetic Patients
  857. Irisin, the novel myokine responsible for benefits of physical exercise on bone
  858. Irisin, turning up the heat
  859. Irisin, two years later
  860. Irisin: A clue for metabolic disorders
  861. Irisin: a hope in understanding and managing obesity and metabolic syndrome
  862. Irisin: a messenger from the gods?
  863. Irisin: a myokine with locomotor activity
  864. Irisin: a new code uncover the relationship of skeletal muscle and cardiovascular health during exercise
  865. Irisin: a new hope for type 2 diabetes and obesity
  866. Irisin: a new molecular marker and target in metabolic disorder
  867. Irisin: a newly described protein hormone that is induced in exercise and acts on adipose tissue
  868. Irisin: a possibly new therapeutic target for obesity and diabetes mellitus
  869. Irisin: a potential link between physical exercise and metabolism—an observational study in differently trained subjects, from elite athletes to sedentary people
  870. Irisin: A POTENTIAL PROMISING AGENT AGAINST NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETIC RATS
  871. Irisin: a potentially candidate marker for myocardial infarction
  872. Irisin: a renaissance in metabolism?
  873. Irisin: a true, circulating hormone
  874. Irisin: As a Therapeutic target for metabolic disorders
  875. Irisin: good or bad for the bone? A new path forward after the reported discovery of Irisin receptor?
  876. Irisin: linking metabolism with heart failure
  877. Irisin: Still chasing shadows
  878. Irisin: what promise does it hold?
  879. Irisin:’fat’or artefact
  880. Irisin/FNDC5–An updated review
  881. Irisin/FNDC5: A participant in camel metabolism
  882. Is Irisin a human exercise gene?
  883. Is Irisin a Phenotypic Parameter in Over-Weight Women with Polycystic Ovary Syndrome?
  884. Is Irisin an anticarcinogenic peptide
  885. Is Irisin an anticarcinogenic peptide?
  886. Is Irisin an early marker of statin-induced myopathy? Bench to the bedside
  887. Is Irisin Anticancer Agent?
  888. Is Irisin the new player in exercise-induced adaptations or not? A 2017 update
  889. Is serum Irisin level lower in neonates born to mothers with gestational diabetes?
  890. Is there a relationship between delivery mode and serum Irisin levels in pregnant women?
  891. Lack of adipocyte-fndc5/Irisin expression and secretion reduces thermogenesis and enhances adipogenesis
  892. Laser-scanning cytometry can quantify human adipocyte browning and proves effectiveness of Irisin
  893. Leptin administration activates Irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice
  894. Leptin administration in physiological or pharmacological doses does not alter circulating Irisin levels in humans
  895. Leptin, adiponectin, tumor necrosis factor alpha, and Irisin concentrations as factors linking obesity with the risk of atrial fibrillation among inpatients with …
  896. Locus characterization and gene expression of bovine FNDC5: is the myokine Irisin relevant in cattle?
  897. Longitudinal variation of circulating Irisin after an energy restriction‐induced weight loss and following weight regain in obese men and women
  898. Low Irisin Levels in Patients with Type 2 Diabetes Mellitus without Current Treatment: A Systematic Review
  899. Low serum concentrations of Irisin are associated with increased risk of hip fracture in Chinese older women
  900. Low serum Irisin concentration is associated with poor outcomes in patients with acute pancreatitis, and Irisin administration protects against experimental acute …
  901. Low serum level of Irisin and gestational diabetes mellitus
  902. Lower circulating Irisin in middle-aged and older adults with osteoporosis: a systematic review and meta-analysis
  903. Lower circulating Irisin is associated with nonalcoholic fatty liver disease and type 2 diabetes
  904. Lower circulating Irisin is associated with type 2 diabetes mellitus
  905. Lower circulating Irisin level in patients with diabetes mellitus: a systematic review and meta-analysis
  906. Lower Irisin level in patients with type 2 diabetes mellitus: A case‐control study and meta‐analysis: 2 型糖尿病患者的低鸢尾素水平: 一项病例对照研究和 meta 分析
  907. Lower Irisin levels in coronary artery disease: a meta-analysis.
  908. Lower Serum Irisin Levels Are Associated with Increased Abdominal Aortic Calcification in Peritoneal Dialysis Patients
  909. Lower serum Irisin levels are associated with increased vascular calcification in hemodialysis patients
  910. LSC Abstract–Irisin stimulates hyaluronic acid secretion in COPD: A new role for Irisin associated with disease progression and severity
  911. Maternal and neonatal Irisin precursor gene FNDC5 polymorphism is associated with preterm birth
  912. Maternal circulating levels of Irisin in intrahepatic cholestasis of pregnancy
  913. Maternal high-fat diet during pregnancy and lactation provokes depressive-like behavior and influences the Irisin/brain-derived neurotrophic factor axis and …
  914. Maternal inheritance of circulating Irisin in humans
  915. Maternal Irisin level in last trimester isolated intrauterine growth-restriction
  916. Maternal serum and fetal cord blood Irisin levels in gestational diabetes mellitus
  917. Maternal serum Irisin levels in early and late-onset pre-eclamptic and healthy pregnancies
  918. Maternal serum, placental, and umbilical venous blood Irisin levels in intrahepatic cholestasis of pregnancy
  919. Measurement of Serum Irisin in Patients with Polycystic Ovary Syndrome
  920. Measurement of serum Irisin in the different stages of chronic kidney disease
  921. Meta-analysis of Irisin Levels in Gestational Diabetes Mellitus
  922. Metabolism: Irisin, the metabolic syndrome and follistatin in humans
  923. Metformin promotes Irisin release from murine skeletal muscle independently of AMP‐activated protein kinase activation
  924. Metformin‐induced autophagy and Irisin improves INS‐1 cell function and survival in high‐glucose environment via AMPK/SIRT1/PGC‐1α signal pathway
  925. Metotreksat kaynaklı böbrek hasarı ve Irisin immünoreaktivitesine karşı benfotiaminin terapötik potansiyeli
  926. Moderate intensity exercise in hypoxia increases IGF-1 bioavailability and serum Irisin in individuals with type 1 diabetes
  927. Modification of Irisin Level in Overweight/Obese Women during Pregnancy and Its Association with Some Metabolic Risk Factors
  928. Modulation of Irisin and physical activity on executive functions in obesity and morbid obesity
  929. Molecular and functional interaction of the myokine Irisin with physical exercise and Alzheimer’s disease
  930. Molecular dynamics simulation and steered molecular dynamics simulation on Irisin dimers
  931. Molecular identification of FNDC5 and effect of Irisin on the glucose metabolism in common carp (Cyprinus carpio L.)
  932. MON-533 Irisin in Post-Menopausal Women with Primary Hyperparathyroidism: An Interplay between Irisin and Pth
  933. Muscle Irisin response to aerobic vs HIIT in overweight female adolescents
  934. Muscle, inflammation and metabolic health: is Irisin the missing link?
  935. Myokine Irisin curtails chondrocyte dysfunction and osteoarthritis through repressing WNT3A signaling
  936. myokine Irisin recapitulates the effect of physical activity on bone and muscle tissues
  937. Myokine Irisin-induced protection against oxidative stress in vitro. Involvement of heme oxygenase-1 and antioxidazing enzymes superoxide dismutase-2 and …
  938. Myokine–adipokine cross-talk: Potential mechanisms for the association between plasma Irisin and adipokines and cardiometabolic risk factors in Mexican …
  939. Myokine—Irisin—and Its Effects Linking Bone and Muscle Function
  940. N-Glycosylation is required for FDNC5 stabilization and Irisin secretion
  941. Nesfatin-1 and Irisin levels in response to the soccer matches performed in morning, afternoon and at night in young trained male subjects
  942. Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and Irisin and MCC950, from an inflammatory perspective–a Commentary
  943. Neuroprotective effects of Irisin against cerebral ischemia/reperfusion injury via Notch signaling pathway
  944. New insight into the direct anti-inflammatory activity of a myokine Irisin against proinflammatory activation of adipocytes: Implication for exercise in obesity
  945. New insights in the bone-muscle axis: the novel myokine Irisin is involved in skeletal metabolism
  946. New insights into the cellular activities of Fndc5/Irisin and its signaling pathways
  947. New insights into the effects of Irisin levels in HIV-infected subjects: correlation with adiposity, fat-free mass, and strength parameters
  948. New role of Irisin in hepatocytes: The protective effect of hepatic steatosis in vitro
  949. Novel adipokines vaspin and Irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus
  950. Novel myokine: Irisin may be an independent predictor for subclinic atherosclerosis in Behçet’s disease
  951. Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk
  952. Obesity and its association with Irisin level among individuals with FNDC5/Irisin gene variants RS16835198 and RS726344
  953. Obesity-associated alterations in the circadian rhythm of the myokine Irisin
  954. Obezite üzerine etkili yeni bir hormon: İrisin
  955. Omentin, vaspin and Irisin in chronic liver diseases
  956. One session of exercise or endurance training does not influence serum levels of Irisin in rats
  957. P035 EXOGENOUS ADMINISTRATION OF Irisin DURING CHRONIC TNBS-INDUCED GUT INFLAMMATION REVERSES INFLAMMATION-INDUCED …
  958. P060 INFLAMMATION-ASSOCIATED COLONIC LYMPHATIC ARCHITECTURE DISRUPTION IS AMELIORATED BY Irisin A CHRONIC RODENT MODEL OF IBD
  959. P166Assessment of the relationship between novel proteins and cardiac cachexia in heart failure patients with reduced ejection fraction: adropin and Irisin
  960. P3195 Impaired functioning and low mass of skeletal muscles in men with heart failure with reduced ejection fraction are reflected by reduced muscle-derived Irisin
  961. Pathophysiological role of endogenous Irisin against tumorigenesis and metastasis: Is it a potential biomarker and therapeutic?
  962. Pattern of Serum Irisin Hormone in Patients with Thyroid Dysfunction
  963. Pbi-072 Exercise hormone (Irisin)
  964. PGC-1 mediates the regulation of metformin in muscle Irisin expression and function
  965. Pharmacological concentrations of Irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal …
  966. Physical exercise stimulates hippocampal mTORC1 and FNDC5/Irisin signaling pathway in mice: Possible implication for its antidepressant effect
  967. Physiology and role of Irisin in glucose homeostasis
  968. Plasma and salivary Irisin levels in lepramatous leprosy patients
  969. Plasma concentration of Irisin and brain-derived-neurotrophic factor and their association with the level of erythrocyte adenine nucleotides in response to long …
  970. PLASMA Irisin AND HEAT SHOCK PROTEIN 70 LEVELS
  971. Plasma Irisin and its associations with oxidative stress in athletes suffering from overtraining syndrome
  972. Plasma Irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients
  973. Plasma Irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients
  974. Plasma Irisin in runners and nonrunners: no favorable metabolic associations in humans
  975. Plasma Irisin is associated with insulin resistance in men (854.4)
  976. Plasma Irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels
  977. Plasma Irisin is increased following 12 weeks of Nordic walking and associates with glucose homoeostasis in overweight/obese men with impaired glucose regulation
  978. Plasma Irisin level associated with hemodynamic parameters and predict clinical outcome in patients with acute pulmonary embolism
  979. Plasma Irisin levels are associated with hemodynamic and clinical outcome in idiopathic pulmonary arterial hypertension patients
  980. Plasma Irisin levels in subjects with type 1 diabetes: comparison with healthy controls
  981. Plasma Irisin levels predict telomere length in healthy adults
  982. Plasma Irisin levels progressively increase in response to increasing exercise workloads in young, healthy, active subjects
  983. Plasma Irisin modestly increases during moderate and high-intensity afternoon exercise in obese females
  984. Plasma levels of Irisin in children with idiopathic premature adrenarche
  985. PO-141 The cardiovascular protection of Irisin and its research progress in sport field
  986. PO-175 Interruption of mitochondrial homeostasis inhibits Irisin biosynthesis in C2C12 Myoblast
  987. PO-212 Effects of hypoxic endurance training on weight loss and Irisin expression in nutritional obese rats
  988. PO-242 Effects of tail suspension on the expression of FNDC5/Irisin protein in rat skeletal muscle
  989. PO-256 Influences of Exercise on Circulating Irisin in Overweight or Obese Individuals: a system review
  990. Pork Consumption and serum Irisin levels in type 2 diabetes
  991. Positive correlation between circulating Irisin concentrations and homeostatic model assessment for insulin resistance (HOMA-IR) in women with Polycystic …
  992. Post-Roux en Y Gastric Bypass Surgery Depletion of Myostatin and Enhancement of Irisin in Youth with Severe Obesity
  993. Postmenopausal osteoporosis is associated with serum chemerin and Irisin but not with apolipoprotein M levels
  994. Potential Effect of Irisin and/or Moderate Intensity Exercise on Metabolic Homeostasis in Obesity in Male Albino Rats
  995. Potential impact of exercise versus Irisin on hypertension, and visceral adiposity in a rat model of type 2 diabetes mellitus
  996. PPAR-α agonist fenofibrate decreased serum Irisin levels in type 2 diabetes patients with hypertriglyceridemia
  997. PPARγ and ADRB3 polymorphisms analysis and Irisin expression in professional water polo players
  998. Preanalytical, analytical, and postanalytical errors in the measurement of Irisin levels.
  999. Preliminary study of the association of serum Irisin levels with poor sleep quality in rheumatoid arthritis patients
  1000. Progress and challenges in the biology of FNDC5 and Irisin
  1001. Promising Effect of Irisin in Reduction of Obesity And Insulin Resistance: A Review
  1002. Protective actions of exercise‐related FNDC5/Irisin in memory and Alzheimer’s disease
  1003. Protective effect of Irisin on atherosclerosis via suppressing oxidized low density lipoprotein induced vascular inflammation and endothelial dysfunction
  1004. Protective effects of benfotiamine on Irisin activity in methotrexate-induced liver injury in rats
  1005. Protective effects of Irisin on hypoxia‐reoxygenation injury in hyperglycemia‐treated cardiomyocytes: Role of AMPK pathway and mitochondrial protection
  1006. PS-042 myokine Irisin is down-regulated in fetal growth restriction
  1007. Recombinant human Irisin regulated collagen II, matrix metalloproteinase‑13 and the Wnt/β‑catenin and NF‑κB signaling pathways in interleukin‑1β‑induced …
  1008. Recombinant Irisin induces weight loss in high fat DIO mice through increase in energy consumption and thermogenesis
  1009. Recombinant Irisin Prevents the Reduction of Osteoblast Differentiation Induced by Stimulated Microgravity through Increasing β-Catenin Expression
  1010. Reduced muscle-derived Irisin reflects low muscles mass and impaired functioning of skeletal muscles in men with heart failure with reduced ejection fraction
  1011. Reduced plasma level of Irisin in first trimester as a risk factor for the development of gestational diabetes mellitus
  1012. Regular aerobic exercise correlates with reduced anxiety and incresed levels of Irisin in brain and white adipose tissue
  1013. Regulation of cell proliferation and malignant potential by Irisin in endometrial, colon, thyroid and esophageal cancer cell lines
  1014. Regulatory role of endothelin-1, brain natriuretic peptide and Irisin in the development of the immune response to short-term general cooling
  1015. Relation of serum Irisin level with metabolic and antropometric parameters in obese children
  1016. Relationship between circulating Irisin levels and overweight/obesity: A meta-analysis
  1017. Relationship between circulating Irisin, renal function and body composition in type 2 diabetes
  1018. Relationship between Irisin concentration and serum cytokines in mother and newborn
  1019. Relationship between myostatin and Irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?
  1020. Relationship between neonatal umbilical cord blood Irisin level and birth weight and intrauterine growth restriction
  1021. Relationship between serum Irisin levels and urinary albumin excretion in patients with type 2 diabetes
  1022. Relationship between serum Irisin, glycemic indices, and renal function in type 2 diabetic patients
  1023. Relationship of circulating Irisin with body composition, physical activity, and cardiovascular and metabolic disorders in the pediatric population
  1024. Relationship of serum Irisin levels to prevalence and progression of coronary artery calcification: A prospective, population-based study
  1025. Relationship of vitamin D-deficient diet and Irisin, and their impact on energy homeostasis in rats
  1026. Relationships Between Circulating Irisin Response to Ice Swimming and Body Composition in People With Regular Exercise Experience
  1027. Relationships between serum Irisin levels and metabolic parameters in Japanese patients with obesity
  1028. Reproductive effects of Irisin: initial in vitro studies
  1029. Research Article Association between Irisin, hs-CRP, and Metabolic Status in Children and Adolescents with Type 2 Diabetes Mellitus
  1030. Research Progress on Irisin and Metabolic Disorders of Polycystic Ovary Syndrome
  1031. Resistance exercise induces a greater Irisin response than endurance exercise
  1032. Resistance exercise training does not affect plasma Irisin levels of hemodialysis patients
  1033. Resistance exercise training increases the expression of Irisin concomitant with improvement of muscle function in aging mice and humans
  1034. Resistance training increases fibroblast growth factor-21 and Irisin levels in the skeletal muscle of Zucker diabetic fatty rats
  1035. RESPONSE OF Irisin, INSULIN AND THE VISCERAL FAT TO MUSCLE MASS RATIO OF SEDENTARY OBESE WOMEN TO 8 WEEKS OF ENDURANCE AND …
  1036. Response to Comment on Wu and Spiegelman. Irisin ERKs the Fat. Diabetes 2014; 63: 381− 383
  1037. Responses of circulating Irisin to different exercises in humans
  1038. Retinoic acid increases fatty acid oxidation and Irisin expression in skeletal muscle cells and impacts Irisin in vivo
  1039. Review of Research on the Role of Irisin in Tumors
  1040. ROCK1 reduces mitochondrial content and Irisin production in muscle suppressing adipocyte browning and impairing insulin sensitivity
  1041. Role Irisin in Induce Metabolic Syndrome
  1042. Role of Betatrophin and Irisin on Diabetes Mellitus Type1 Management (Experimental Study).
  1043. Role of endogenous Irisin, a novel myokine, in cognitive functions and insulin sensitivity in exercised diabetic rats
  1044. Role of Hormone Irisin in Induce Metabolic Syndrome
  1045. Role of Irisin administration in modulating testicular function in adult obese albino rats
  1046. Role of Irisin administration in modulating testicular function in adult obese albino rats
  1047. Role of Irisin in androgen-deficient muscle wasting and osteopenia in mice
  1048. Role of Irisin in androgen-deficient muscle wasting and osteopenia in mice
  1049. Role of Irisin in Chinese patients with hypothyroidism: an interventional study
  1050. Role of Irisin in Diabetes
  1051. Role of Irisin in effects of chronic exercise on muscle and bone in ovariectomized mice
  1052. Role of Irisin on the bone–muscle functional unit
  1053. Role of Kidney Injury Molecule-1 Expression, Wnt Proteins (Beta-catenin) and Endogenous Irisin in a Rat Model of Renal fibrosis: Renoprotective Effect of Metformin
  1054. Role of MANF, TIMP-2, and Irisin Proteins in Aging
  1055. Role of serum levels of Irisin and oxidative stress markers in pregnant women with and without gestational diabetes
  1056. Role of swimming on muscle PGC-1α, FNDC5 mRNA, and assessment of serum omentin, adropin, and Irisin in high carbohydrate high fat (HCHF) diet …
  1057. Roles of FGF21 and Irisin in obesity-related diabetes and pancreatic diseases
  1058. Roles of Irisin in the linkage from muscle to bone during mechanical unloading in mice
  1059. Sabah ve gece yapılan aerobik egzersizin antrenmanlı deneklerde serum Irisin düzeyine etkilerinin belirlenmesi
  1060. SAT-060 SERUM Irisin LEVEL IS POSITIVELY ASSOCIATED WITH BONE MINERAL DENSITY IN PATIENTS ON CHRONIC HEMODIALYSIS
  1061. SERUM ADIPONECTIN AND Irisin LEVELS IN OVARIECTOMIZED OSTEOPOROTIC RAT MODEL
  1062. Serum and adipose tissue mRNA levels of ATF3 and FNDC5/Irisin in colorectal cancer patients with or without obesity
  1063. Serum and follicular fluid Irisin levels in poor and high responder women undergoing IVF/ICSI
  1064. Serum and follicular fluid Irisin levels in women with polycystic ovaries undergoing ovarian stimulation: Correlation with insulin resistance and lipoprotein lipid profiles
  1065. Serum betatrophin and Irisin levels in hepatocellular carcinoma
  1066. Serum Irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism
  1067. Serum Irisin and its regulation by hyperinsulinemia in women with polycystic ovary syndrome
  1068. Serum Irisin and myostatin levels after 2 weeks of high-altitude climbing
  1069. Serum Irisin and oxytocin levels as predictors of metabolic parameters in obese children
  1070. Serum Irisin associates with breast cancer to spinal metastasis
  1071. Serum Irisin Changes Following Endurance Exercise and Caloric Restriction in Obese and Hypertriglyceridemic Rats
  1072. Serum Irisin concentration in women with gestational diabetes
  1073. Serum Irisin Concentrations in Lean Adolescents with Polycystic Ovary Syndrome
  1074. Serum Irisin concentrations in lean adolescents with polycystic ovary syndrome
  1075. Serum Irisin Concentrations in Severely Inflamed Patients
  1076. Serum Irisin concentrations were increased after transient continuous subcutaneous insulin infusion in type 2 diabetes mellitus patients
  1077. Serum Irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status
  1078. Serum Irisin level can predict the severity of coronary artery disease in patients with stable angina
  1079. Serum Irisin level changes after propylthiouracil treatment of L-thyroxine induced hyperthyroidism in rats
  1080. Serum Irisin level in different thyroid dysfunction states and its relation to markers of muscle dysfunction
  1081. Serum Irisin level in myocardial infarction patients with or without heart failure
  1082. Serum Irisin level in patients undergoing different Stages of Chronic Kidney Disease
  1083. Serum Irisin level increases throughout the gestational period and it does not play a role in development of gestational diabetes mellitus
  1084. Serum Irisin level increases throughout the gestational period and it does not play role in development of gestational diabetes mellitus
  1085. Serum Irisin level is higher and related with insulin in acanthosis nigricans-related obesity
  1086. Serum Irisin level, insulin resistance, and lipid profiles in patients with hidradenitis suppurativa: a case-control study
  1087. Serum Irisin Levels and Cardiovascular Outcomes in Patients With Acute Myocardial Infarction
  1088. Serum Irisin Levels and Clinical Implication in Elderly Patients With Type 2 Diabetes Mellitus
  1089. Serum Irisin levels and thyroid function—Newly discovered association
  1090. Serum Irisin levels are associated with adverse cardiovascular outcomes in patients with acute myocardial infarction
  1091. Serum Irisin levels are correlated with insulin resistance in women with gestational diabetes mellitus
  1092. Serum Irisin levels are decreased in patients with sepsis, and exogenous Irisin suppresses ferroptosis in the liver of septic mice
  1093. Serum Irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics
  1094. Serum Irisin levels are regulated by acute strenuous exercise
  1095. Serum Irisin levels as a marker in some phenotypes of PCOS
  1096. Serum Irisin levels as a potential marker for diagnosis of gestational diabetes mellitus
  1097. Serum Irisin levels correlated to peritoneal dialysis adequacy in nondiabetic peritoneal dialysis patients
  1098. Serum Irisin Levels in Central Precocious Puberty and Its Variants
  1099. Serum Irisin levels in chronic open-angle glaucoma
  1100. Serum Irisin levels in metabolically healthy versus metabolically unhealthy obesity: A case-control study
  1101. Serum Irisin levels in new-onset type 2 diabetes
  1102. Serum Irisin levels in normotensive and preeclamptic pregnancies
  1103. Serum Irisin Levels in Patients with Acute Atrial Fibrillation
  1104. Serum Irisin levels in patients with polycystic ovary syndrome
  1105. Serum Irisin levels in patients with psoriasis
  1106. Serum Irisin levels in polycystic ovary syndrome after ovarian drilling
  1107. Serum Irisin Levels, Endothelial Dysfunction, and Inflammation in Pediatric Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome
  1108. Serum Irisin levels, precocious myocardial infarction, and healthy exceptional longevity
  1109. Serum Irisin predicts mortality risk in acute heart failure patients
  1110. Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma
  1111. Serum Irisin, adropin, and preptin in obese patients 6 months after bariatric surgery
  1112. Serum Irisin: A prognostic marker for severe acne vulgaris
  1113. Serum Irisin: pathogenesis and clinical research in cardiovascular diseases
  1114. Serum Levels of Irisin and Vaspin in Diabetic Retinopathy Patients and Their Relation to Patient’s Obesity
  1115. Serum levels of Irisin in gestational diabetes mellitus during pregnancy and after delivery
  1116. Serum levels of Irisin predict short-term outcomes in ischemic stroke
  1117. Serum levels of nesfatin-1 and Irisin in obese children
  1118. Serum levels of nesfatin-1 and Irisin in obese children
  1119. Serum Levels of Novel Biochemical Marker (Irisin) in Relation to the Duration of Type 2 Diabetes & in Cases of Type 2 diabetes with Coronary Artery Disease …
  1120. Serum levels of the adipomyokine Irisin in patients with chronic kidney disease
  1121. Serum levels of the myokine Irisin are predicted by markers of insulin resistance during pregnancy and after delivery
  1122. Serum levels of the myokine Irisin in relation to metabolic and renal function
  1123. Serum levels of visfatin, omentin and Irisin in patients with end-stage lung disease before and after lung transplantation
  1124. Serum sclerostin and Irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study
  1125. Serum, saliva, and urine Irisin with and without acute appendicitis and abdominal pain
  1126. Sex-dependent association between circulating Irisin levels and insulin resistance in healthy adults
  1127. Short peptides and telomere length regulator hormone Irisin
  1128. Simvastatin Increases Irisin Concentrations in Human Subjects in Vivo and Irisin Expression and Secretion in Human Skeletal Muscle Cells ex Vivo
  1129. SMAD3 negatively regulates serum Irisin and skeletal muscle FNDC5 and peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) during …
  1130. Small interfering RNA mediated knockdown of Irisin suppresses food intake and modulates appetite regulatory peptides in zebrafish
  1131. SNPs in FNDC5 (Irisin) are associated with obesity and modulation of glucose and lipid metabolism in Saudi subjects
  1132. Study of Irisin hormone level in type 2 diabetic patients and patients with diabetic nephropathy
  1133. Study of Irisin hormone level in type 2 diabetic patients with and without diabetic neuropathy
  1134. Study of Irisin Level and Many Biochemical Parameters in Patients with Diabetic Mellitus in Kirkuk City
  1135. Study of Serum Irisin in Patients with Thyroid Dysfunction
  1136. Study on the correlation between serum Irisin and type 2 diabetic nephropathy
  1137. Study on the distribution and elimination of the new hormone Irisin in vivo: new discoveries regarding Irisin
  1138. Study on the relationship between the levels of Irisin in umbilical cord blood and neonatal growth in China
  1139. Study the Effect of Irisin on Prostate Cancer Cells
  1140. Study the role of maternal Irisin levels with preterm and term delivery
  1141. STUDYING THE EFFECT OF 8 WEEKS OF HICT ON SERUM LEVELS OF BDNF AND Irisin AND BODY WEIGHT IN ELDERLY WOMEN WITH METABOLIC …
  1142. SUN-066 Circulating Irisin and Correlation with Antioxidant Systems in Different Models of Heart Failure
  1143. Superiority of the non-glycosylated form over the glycosylated form of Irisin in the attenuation of adipocytic meta-inflammation: a potential factor in the fight against …
  1144. Supervised short-term high-intensity training on plasma Irisin concentrations in type 2 diabetic patients
  1145. Swimming exercise increases serum Irisin level and reduces body fat mass in high-fat-diet fed Wistar rats
  1146. Swimming intervention mitigates HFD-induced obesity of rats through PGC-1a-Irisin pathway
  1147. Swimming intervention mitigates HFD-induced obesity of rats through PGC-1α-Irisin pathway.
  1148. Swimming training attenuates allodynia and hyperalgesia induced by peripheral nerve injury in an adult male rat neuropathic model: effects on Irisin and GAD65
  1149. Synergism effects of ursolic acid supplementation on the levels of Irisin, C-reactive protein, IL-6, and TNF-α during high-intensity resistance training in low activity men
  1150. Synergistic effect of carnosine on browning of adipose tissue in exercised obese rats; a focus on circulating Irisin levels
  1151. Synergistic Effects of Leucine and its Metabolites with Polyphenols on Irisin in Myotubes and Diet‐induced Obese Mice
  1152. Target of Exercise Intervention in AD—Muscle Factor Irisin
  1153. Taurine supplementation increases Irisin levels after high intensity physical training in obese women
  1154. The “Irisin system”: From biological roles to pharmacological and nutraceutical perspectives
  1155. The 148 M allele of the PNPLA3 is associated with plasma Irisin levels in a population sample of Caucasian children: the PANIC Study
  1156. The adaptability of serum Irisin, lipid profile, and insulin resistance to an aerobic exercise and the consumption of saffron and its sustainability in type 2 …
  1157. The Alteration of Irisin—Brain-Derived Neurotrophic Factor Axis Parallels Severity of Distress Disorder in Bronchial Asthma Patients
  1158. The association between circulating Irisin levels and different phenotypes of polycystic ovary syndrome
  1159. The association between increased circulating Irisin levels and inflammatory markers in polycystic ovary syndrome
  1160. The association between Irisin and muscle metabolism in different thyroid disorders
  1161. The association between Irisin levels, element distribution and oxidative stress markers in adolescent swimmers
  1162. The association between serum Irisin levels and cardiovascular disease in diabetic patients
  1163. The association of circulating Irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study
  1164. THE ASSOCIATION OF Irisin, RETINOL BINDING PROTEIN 4 (RBP4) AND LEPTIN AS MARKERS OF INFLAMATION WITH CARDIOVASCULAR COMPLICATIONS …
  1165. The association of oxidative stress with serum Irisin and betatrophin in pregnant women with gestational diabetes mellitus
  1166. The beneficial effect of electro acupuncture on obesity may be associated with Irisin, nesfatin-l and preptin levels
  1167. The bone anabolic effects of Irisin are through preferential stimulation of aerobic glycolysis
  1168. The cardiovascular protection of Irisin and its research progress in sports field
  1169. The Changes of Irisin Levels in Athletes after Eight Weeks Intensity Internal Training
  1170. The changes of Irisin serum levels and lipid profile of overweight male students after eight weeks of aerobic training
  1171. The clinical significance of serum levels of tenascin-C and Irisin in patients with H-type hypertension complicated with acute ischemic stroke
  1172. The colors of adipose tissue and the relationship with Irisin.
  1173. The Combination of Aerobic and Resistance Exercise Induces Weight Loss via the PGC-1α/Irisin/UCP-1 Pathway
  1174. The combination of exercise training and Zataria multiflora supplementation increase serum Irisin levels in postmenopausal women
  1175. The Comparison of 8 week combined training with two different intensity on level of serum Irisin, and glycemic indices of type 2 diabetic women
  1176. The Correlation of Irisin Levels and Some Trace Element as a Potential Mark Diagnosis of Gestational Diabetes Mellitus
  1177. THE CORRELATION OF Irisin LEVELS AND SOME TRACE ELEMENT AS A POTENTIAL MARK FOR DIAGNOSIS OF GESTATIONAL DIABETES MELLITOUS
  1178. The Correlation of Maternal and Fetal Blood Irisin with Fetal Growth Pattern and Birth Weight
  1179. The data on the aerobic training with or without calorie restriction and muscular levels of Irisin and muscular FNDC5 concentration in obese male Wistar rats
  1180. The diagnostic and prognostic roles of serum Irisin in bladder cancer
  1181. The diagnostic value of FNDC5/Irisin in renal cell cancer
  1182. The Diagnostic Value of Irisin and Visfatin in Experimental Testicular Torsion
  1183. The diagnostic value of Irisin in patients with acute abdominal pain: A preliminary study
  1184. The diagnostic value of Irisin in pediatric patients with acute abdominal pain
  1185. The diagnostic value of the serum Irisin level in patients with acute pericarditis and acute myopericarditis.
  1186. The effect of 14 weeks of endurance training with two different Intensity on serum Irisin level, gene expression of skeletal muscle PGC1-α and FNDC5 and …
  1187. The Effect of 16 Weeks of Low Calorie Diet on Irisin Serum Levels and Insulin Resistance Index in Obese Sedentary Women
  1188. The effect of 3 weeks ergometer cycling training with and without vascular occlusion on Plasma concentration of Irisin and PGC-1α in healthy men
  1189. The effect of 4-week endurance training on serum levels of Irisin and betatrophin in streptozotocin-induced diabetic rats
  1190. THE EFFECT OF 8 WEEKS AEROBIC TRAINING ON CARDIAC PGC-1Α AND PLASMA Irisin IN STZ-INDUCED DIABETICS’RATS
  1191. The effect of 8 weeks resistance and concurrent training on Irisin, some glycemic indexes and the visceral fat to muscle mass ratio on sedentary obese women
  1192. The Effect of 8-Week Circuit resistance training and Spirulina Supplementation on Plasma Levels of Irisin and Some Body composition in Overweight and Obese Men
  1193. The effect of a four week aerobic training on serum levels of Irisin and insulin resistance in women with type 2 diabetes
  1194. The Effect of Acute Aerobic Exercise after Consumption of four Different Diets on Serum Levels Irisin in Overweight Men
  1195. The effect of acute exercise and gender on the levels of Irisin in elite athletes
  1196. The effect of eight weeks aerobic training on serum Irisin, glucose homeostasis and blood lipid levels in untrained women
  1197. THE EFFECT OF EIGHT WEEKS HIGH INTENSITY INTERVAL TRAINING (HIIT) ON SERUM AMOUNTS OF FGF21 AND Irisin IN SEDENTARY OBESE WOMEN
  1198. The Effect of Eight Weeks High-Intensity Interval Training (HIT) on of Irisin Levels in Obese Young Men
  1199. The Effect of Eight Weeks of High Intensity Interval Training (Hiit) on Serum Irisin, Fgf21 and Glycemic Indices in Type 2 Diabetic Women
  1200. The effect of eight weeks pilates training on plasma Irisin levels and anthropometric parameters in overweight women
  1201. The Effect of Ethanol on Skeletal Muscle Endocrine Function and the Novel Myokines Myonectin and Irisin
  1202. The Effect of Exercise On Fat Browning through Plasma Irisin Level Modulation to Overcome Obesity
  1203. The effect of fenugreek seed supplementation on serum Irisin levels, blood pressure, and liver and kidney function in patients with type 2 diabetes mellitus: A parallel …
  1204. The Effect of Ginger Supplementation and High Intensity Interval Training (HIIT) on Anthropometric Indices and Serum Level of Irisin in Obese Men
  1205. The effect of high intensity interval training (HIIT) and pilates on levels of Irisin and insulin resistance in overweight women
  1206. The effect of high intensity interval training on levels of Irisin, lipid profile and body composition in overweight subjects
  1207. The Effect of High Intensity Interval Training on the Serum Levels of Irisin and Fibroblastic Growth Factor-21 (Fgf-21), and Insulin Resistance in Obese Male Rats
  1208. The Effect of High Intensity Interval Training with Vitamin E Consumption on Serum Levels of Irisin and Gene Expression of Membrane Protein FNDC5 of Soleus …
  1209. The Effect of High Intensity Interval Training with Vitamin E Consumption on Serum Levels of Irisin and Gene Expression of Membrane Protein FNDC5 of Soleus …
  1210. The effect of high protein diet and exercise on Irisin, eNOS, and iNOS expressions in kidney
  1211. The effect of high-intensity Interval training and L-arginine supplementation on serum level of Irisin and body fat percentage in overweight and obese men: A …
  1212. The effect of His-tag and point mutation on the activity of Irisin on MC3T3-E1 cells
  1213. The effect of hypothyroidism on serum Irisin level in patients with nondiabetic chronic kidney disease: A pilot study with a cross-sectional design
  1214. The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and Irisin levels
  1215. The effect of intrathecal injection of Irisin on pain threshold and expression rate of GABAB receptors in peripheral neuropathic pain model
  1216. The effect of Irisin on antioxidant system in liver
  1217. The effect of Irisin on bone cells in vivo and in vitro
  1218. The Effect of Kinesitherapy Exercises on the Level of Irisin among Females with Cardio-vascular diseases depending on the body mass and hormonal status.
  1219. The Effect of Milk Consumption after Resistance Training on Glycemic Control and Irisin Levels in Type 2 Diabetic Men: A Semi Experimental Study
  1220. The effect of n-3 polyunsaturated fatty acids supplementation on serum Irisin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled …
  1221. The effect of nutrition and exercise training on Irisin and semaphorin-3E levels in obese patients
  1222. The Effect of Obesity and Its Subsequent Intense Endurance Training on Serum Irisin Concentration and Expression of Subcutaneous Adipose Tissue UCP1 mRNA …
  1223. The Effect of Obesity and Its Subsequent Intense Endurance Training on Serum Irisin Concentration and Expression of Subcutaneous Adipose Tissue UCP1 mRNA …
  1224. The Effect of Pubertal Stage on the Concentrations of the Novel Adipomyokine, Irisin, in Male Adolescents
  1225. The effect of resistance exercise order on serum Irisin and blood lactate concentration in overweight women
  1226. The Effect of Resistance Training on Irisin and Gene Expression of PGC1α in the Cardiac Muscle in STZ-Induced Diabetic Rats
  1227. The effect of selective aerobic training on serum Irisin levels and insulin resistance index in women with type 2 diabetes
  1228. The effect of sleeve gastrectomy on serum Irisin levels in patients with morbid obesity
  1229. The effect of submaximal aerobic training on serum Irisin level in obese men; with emphasis on the role of Irisin in insulin-resistance change
  1230. The Effect of Two Acute Eccentric and Concentric Exercises on Serum Irisin Level and Insulin Resistance Index in Inactive Obese Women
  1231. The effect of two concurrent exercise modalities on serum concentrations of FGF21, Irisin, follistatin, and myostatin in men with type 2 diabetes mellitus
  1232. THE EFFECT OF TWO TYPES OF INTERVENTION (AEROBIC EXERCISE AND CALORIC RESTRICTION) ON SERUM Irisin LEVELS AND INSULIN RESISTANCE …
  1233. The Effect of Vitamin D Supplementation on Serum and Muscle Irisin Levels, and FNDC5 Expression in Diabetic Rats
  1234. The effectiveness of military physical exercise on Irisin concentrations and oxidative stress among male healthy volunteers
  1235. The Effects of a High Fat Diet and Exercise on the PGC-1alpha-FNDC5/Irisin Pathway in C57BL/6 Mice
  1236. The effects of acute and chronic exercise on PGC‐1α, Irisin and browning of subcutaneous adipose tissue in humans
  1237. The effects of aerobic, resistance, and combined exercises on the plasma Irisin levels, HOMA-IR, and lipid profiles in women with metabolic syndrome: A …
  1238. The effects of both age and sex on Irisin levels in paired plasma and cerebrospinal fluid in healthy humans
  1239. The effects of cold water immersion post repeated sprint activity on serum PGC-1α and Irisin in young active men
  1240. The effects of exercise regimens on Irisin levels in obese rats model: Comparing high-intensity intermittent with continuous moderate-intensity training
  1241. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and Irisin in patients with nonalcoholic fatty liver …
  1242. The effects of green cardamom supplementation on blood glucose, lipids profile, oxidative stress, sirtuin-1 and Irisin in type 2 diabetic patients: a study …
  1243. The Effects Of High Intensity Interval Exercise (Hiie) And Moderate Intensity Continuous Exercise (Mice) On Serum Irisin And Subcutaneous Ucp-1 In Diabetic Male …
  1244. The effects of high-intensity interval training vs. moderate-intensity continuous training on serum Irisin and expression of skeletal muscle PGC-1α gene in male rats
  1245. The effects of intracerebroventricular infusion of Irisin on feeding behaviour in rats
  1246. The Effects of Irisin on L-Name Induced Hypertension in Rats Aydoğdu et al. Effect of Irisin on Hypertension
  1247. The Effects of Irisin on Nω-Nitro-L-arginine Methyl Ester Hydrochloride-Induced Hypertension in Rats
  1248. The effects of Irisin on the transforming growth factor-beta1 (TGF-β1) level in type-1 diabetic patients in Thi-Qar province.
  1249. The effects of kumiss supplementation on body weight, food intake, nesfatin-1 and Irisin levels in BALB/C mice
  1250. The Effects of MiR-214-3p and Irisin/FNDC5 on the Biological Behavior of Osteosarcoma Cells
  1251. The effects of peripherally-subacute treatment with Irisin on hippocampal dendritogenesis and astrocyte-secreted factors
  1252. The effects of resistance exercise training followed by de-training on Irisin and some metabolic parameters in type 2 diabetic rat model
  1253. The effects of royal jelly and tocotrienol‐rich fraction on impaired glycemic control and inflammation through Irisin in obese rats
  1254. The Effects of Strenght Exercises on Body Composition and Irisin
  1255. The effects of taurine supplementation on serum levels of adiponectin, Irisin, fibroblast growth factor-21, sirtuin-1, metabolic parameters, oxidative/inflammatory …
  1256. The Effects of Two Acute Eccentric and Concentric Exercises on Serum Irisin Level and Insulin Resistance Index in Inactive Obese Women
  1257. The effects of valsartan and amlodipine on the levels of Irisin, adropin, and perilipin
  1258. The exercise-induced Irisin is associated with improved levels of glucose homeostasis markers in pregnant women participating in 8-week prenatal group …
  1259. The exercise-induced myokine Irisin does not show an association with depressiveness, anxiety and perceived stress in obese women
  1260. The GH treatment results in the increase of Irisin concentration in plasma
  1261. THE GROWTH HORMONE TREATMENT RESULTS IN THE INCREASE OF Irisin CONCENTRATION IN PLASMA
  1262. THE GROWTH HORMONE TREATMENT RESULTS IN THE INCREASE OF Irisin CONCENTRATION IN PLASMA
  1263. The Growth Hormone Treatment Results in the Increase of Irisin Concentration in Plasma
  1264. The identification of Irisin in human cerebrospinal fluid: influence of adiposity, metabolic markers, and gestational diabetes
  1265. The immunomodulatory role of Irisin on osteogenesis via AMPK-mediated macrophage polarization
  1266. The impact of acute resistance training on Irisin in younger and older adults living with overweight or obesity
  1267. The Impact of Different Modes of Exercise Training on Irisin: A Systematic Review and Meta-Analysis Research
  1268. The Impact of Different Modes of Exercise Training on Irisin: A Systematic Review and Meta-Analysis Research
  1269. THE IMPACT OF INTENSITY INTERVAL TRAINING AND SUPPLEMENTATION OF GREEN TEA ON SERUM LEVELS OF Irisin, INSULIN RESISTANCE IN OBESE …
  1270. The influence of bariatric surgery on serum levels of Irisin and nesfatin-1
  1271. The influence of concurrent training intensity on serum Irisin and abdominal fat in postmenopausal women
  1272. The Irisin hormone profile and expression in human bone tissue in the bone healing process in patients
  1273. The Levels of Serum Irisin as a Predictor of Insulin Resistance in Han Chinese Adults with Metabolically Healthy Obesity.
  1274. The modulatory effects of Irisin on asprosin, leptin, glucose levels and lipid profile in healthy and obese male and female rats
  1275. The myokine Irisin improves bone quality and strength
  1276. The myokine Irisin increases cortical bone mass
  1277. The myokine Irisin is released in response to saturated fatty acids and promotes pancreatic β-cell survival and insulin secretion
  1278. The myokine Irisin stimulates osteoclast differentiation and function
  1279. The myokine Irisin: localization and effects in swine late medium and large antral ovarian follicle
  1280. The Neuroprotective Effect of Irisin in Ischemic Stroke
  1281. The novel exercise-induced hormone Irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the …
  1282. The novel myokine Irisin interacts with hyaluronic acid in a cell-specific way and in association with COPD progression and severity
  1283. The novel myokine Irisin: clinical implications and potential role as a biomarker for sarcopenia in postmenopausal women
  1284. The optimal therapeutic Irisin dose intervention in animal model: A systematic review
  1285. The optimal therapeutic Irisin dose intervention in animal model: A systematic review, Veterinary World, 13 (10): 2191-2196
  1286. The p38–PGC-1α–Irisin–betatrophin axis: Exploring new pathways in insulin resistance
  1287. The potential of Irisin as a therapeutic for diabetes
  1288. The potential role of Irisin in the thermoregulatory responses to mild cold exposure in adults
  1289. The Potential Role of Irisin in Vascular Function and Atherosclerosis: A Review
  1290. The protective effect of Irisin against ischemia-reperfusion injury after perforator flap grafting in rats
  1291. The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating Irisin to metabolic phenotype
  1292. The RELATION OF SERUM Irisin LEVEL WITH METABOLIC AND HORMONAL CHANGES IN RAT MODEL OF POLYCYSTIC OVARY
  1293. The relationship between brain-derived neurotrophic factor, Irisin and cognitive skills of endurance athletes
  1294. The relationship between circulating Irisin levels and endothelial function in lean and obese subjects
  1295. The relationship between circulating Irisin levels and tissues AGE accumulation in type 2 diabetes patients
  1296. The relationship between circulating Irisin, retinol binding protein-4, adiponectin and inflammatory mediators in patients with metabolic syndrome
  1297. THE RELATIONSHIP BETWEEN PHYSICAL ACTIVITY STATUS AND SERUM Irisin AND MYOSTATIN LEVELS IN PATIENTS WITH NON-DIALYSIS CHRONIC …
  1298. The Relationship Between Precocious Puberty and Premature Thelarche withSerum Irisin Levels
  1299. The relationship between serum Irisin levels and erectile dysfunction in diabetic men (Irisin and erectile dysfunction in diabetic patients)
  1300. The relationship between serum Irisin, thyroid function and body composition in patients with chronic kidney disease.
  1301. The Relationship between the Serum Irisin Levels and the Metabolic Control in adolescents with Type 1 Diabetes
  1302. The relationship of Irisin with metabolic syndrome components and insulin secretion and resistance in schoolchildren
  1303. The relationships of Irisin with bone mineral density and body composition in PCOS patients
  1304. The response of Irisin serum and insulin resistance to acute Pilates training sessions Pilates training in obese sedentary women
  1305. The response of Irisin serum levels to eight weeks aerobic training with moderate intensity in obese male Wistar rats
  1306. The role of fibroblast growth factor 21 and Irisin in the pathogenesis of obesity in childhood and adolescence
  1307. The role of FNDC5 gene expression in Irisin level changes accompanying thyroid pathologies
  1308. The Role of FNDC5/Irisin in the Nervous System and as a Mediator for Beneficial Effects of Exercise on the Brain
  1309. The role of Irisin in Alzheimer’s disease
  1310. The role of Irisin in ischemic heart disease
  1311. The role of Irisin in multiorgan protection
  1312. The role of Irisin in the relationship between psoriasis and insulin resistance.
  1313. The Role of Irisin, Copper and Zinc Levels on Insulin Resistance in Polycystic Ovary Syndrome
  1314. The role of Irisin, insulin and leptin in maternal and fetal interaction
  1315. The role of myokine Irisin on bone metabolism
  1316. The Role of p53 Synthetic Lethality in Increased Chemosensitivity to DNA-Damaging Agents Conferred by the Exercise Myokine Irisin
  1317. The role of sex, adiposity, and gonadectomy in the regulation of Irisin secretion
  1318. The roles of triiodothyronine and Irisin in improving the lipid profile and directing the browning of human adipose subcutaneous cells
  1319. The serum Irisin level in non-diabetic patients with chronic kidney disease
  1320. The serum level of Irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
  1321. The serum level of Irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
  1322. The structure of Irisin reveals a novel intersubunit β-sheet fibronectin type III (FNIII) dimer: implications for receptor activation
  1323. The T allele of the rs1746661G/T polymorphism in FNDC5 (Irisin) gene is associated with increased systolic blood pressure
  1324. The Time-Course of Antioxidant Irisin Activity: Role of the Nrf2
  1325. The Time-Course of Antioxidant Irisin Activity: Role of the Nrf2/HO-1/HMGB1 Axis
  1326. The whole body cryostimulation modifies Irisin concentration and reduces inflammation in middle aged, obese men
  1327. Three new players in energy regulation: preptin, adropin and Irisin
  1328. THU0080 Serum Irisin and myostatin levels in patients with rheumatoid arthritis
  1329. Thyroid hormones modulate Irisin concentrations in patients with recently onset hypothyroidism following total thyroidectomy
  1330. Time-dependent changes in increased levels of plasma Irisin and muscle PGC-1α and FNDC5 after exercise in mice
  1331. Time-dependent Irisin concentration changes in patients affected by overt hypothyroidism
  1332. Treating Neuroinflammation with the Novel Hormone Irisin
  1333. Treatment with long acting muscarinic antagonists stimulates serum levels of Irisin in patients with COPD
  1334. TRPV4 is involved in Irisin-induced endothelium-dependent vasodilation
  1335. Tu1692 THE ASSOCIATION OF SARCOPENIA WITH MYOSTATIN, FOLLISTATIN AND Irisin LEVELS IN CIRRHOTIC PATIENTS: A MULTICENTER CROSS …
  1336. Type 2 diabetes with hypertensive patients results in changes to features of adipocytokines: Leptin, Irisin, LGR4, and Sfrp5
  1337. Update: Does Irisin Have an Effect on Female Reproductive Function? Initial In-Vitro Studies
  1338. Urotensin II Induces Mice Skeletal Muscle Atrophy Associated with Enhanced Autophagy and Inhibited Irisin Precursor (Fibronectin Type III Domain Containing 5) …
  1339. Ursolic Acid-induced elevation of serum Irisin augments muscle strength during resistance training in men
  1340. Variations in Irisin, bone mineral density, bone mineral content, and body composition after laparoscopic bariatric procedures in obese adults
  1341. Variations in leptin, nesfatin-1 and Irisin levels induced by aerobic exercise in young trained and untrained male subjects
  1342. Vitamin D supplementation improves SIRT1, Irisin, and glucose indices in overweight or obese type 2 diabetic patients: a double-blind randomized placebo …
  1343. Weight Loss: A New Star is Irisin
  1344. What the discovery of Irisin receptor means to bone
  1345. Yeni Hormonlar: R-Spondin-1, Nesfatin-1 ve İrisin
  1346. β-arrestin-2 is involved in Irisin induced glucose metabolism in type 2 diabetes via p38 MAPK signaling
  1347. β-hydroxy-β-methylbutyrate supplementation benefits the effects of resistance training on body fat reduction via increased Irisin expression in white adipose tissue.
  1348. … , skeletal muscle and serum Irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more Irisin than skeletal muscle
  1349. … and pharmacological effects of melatonin on remote ischemic perconditioning after myocardial ischemia‐reperfusion injury in rats: Role of Cybb, Fas, NfκB, Irisin …
  1350. … between the effects of two different frequencies of aerobic exercise with the same volume and detraining period on the levels of Irisin hormone, lipid profiles, and …
  1351. … biomarkers of cognition, stress, and physical or cognitive training in older adults at risk of dementia: preliminary evidence for a role of BDNF, Irisin, and the kynurenine …
  1352. … Controlled Trial on the Effects of 12 Weeks of Aerobic, Resistance, and Combined Exercises Training on the Serum Levels of Nesfatin-1, Irisin-1 and HOMA …
  1353. … end diastolic size of a myocardium of the left ventricle according to an echocardiography in patients with hypertension in combination with obesity depending on Irisin …
  1354. … EXERCISES BESIDE CONSUMPTION OF OMEGA-3, L-CARNITINE SUPPLEMENTS ON THE SERUM LEVEL OF Irisin, RESISTANCE INSULIN, PROFILE LIPID OF …
  1355. … HMB-FA supplementation with or without eccentric resistance exercise on expression of some genes related to muscle protein turnover and serum Irisin and IGF-1 …
  1356. … of exercise intensity and consideration of a dose–response is essential. Commentary on “Exercise-linked FNDC5/Irisin rescues synaptic plasticity and …
  1357. … Training Attenuates Allodynia and Hyperalgesia Induced by Peripheral Nerve Injury in an Adult Male Rat Neuropathic Model: Effects on Irisin and GAD65. Pain Med …
  1358. < The> effect of a four week aerobic training on serum levels of Irisin and insulin resistance in women with type 2 diabetes
  1359. 2094-P: Effects of Irisin on Human Pancreatic Islets from Type 2 Diabetic Subjects
  1360. 312-LB: Irisin, Meteorin-Like Protein, and Bone Remodeling Markers in T2D and Obesity
  1361. 5 years later: Irisin detection still an issue

Related Posts

Shopping Cart
Scroll to Top